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This thesis is submitted in partial fulfilment of the requirements for the degree of 
Doctorate of Clinical Psychology from the University of Birmingham. The thesis consists of 
two volumes. Volume I includes a literature review and an empirical paper. Volume II 
consists of four Clinical Practice Reports and an abstract for a fifth, an oral presentation. Each 
report relates to work undertaken at different clinical placements.    
Volume I 
Volume I comprises three chapters. The first chapter is a systematic literature review 
synthesising evidence on the longitudinal relationship between depressive symptoms and 
metabolic control in adolescents with Type 1 diabetes. The focus of the review is on issues of 
directionality within this relationship over time and ascertaining factors that may influence 
identified longitudinal associations. This chapter was prepared with the intention of 
submission to the journal Diabetes Research and Clinical Practice (See Appendix i for 
instructions for authors). The second chapter is an empirical paper exploring the role of 
cognitive mechanisms in depressive symptoms in adolescents with Type 1 diabetes. The 
cognitions that were investigated were negative automatic thoughts as proposed by Beck’s 
cognitive theory of depression (1967), and self-efficacy, as per Bandura’s social cognitive 
theory (1997). This chapter was prepared for submission to the Journal of Paediatric 
Psychology (See Appendix ii for instructions for authors). The third chapter is a public 
domain briefing document that provides a summary of the findings of the systematic literature 
review and the empirical paper.   
Volume II  
This volume presents four written Clinical Practice Reports and an abstract for a 
clinical practice report that was presented orally. The first report details the case of a 24-year 
old male with a mild learning disability who was experiencing elevated levels of anxiety. The 
assessment is described alongside cognitive behavioural and psychodynamic formulations of 
the presenting difficulty. The second report presents the evaluation of a community learning 
disabilities service based on recommendations for service provision to adults with profound 
and multiple learning disabilities. The third report documents an A-B single-case 
experimental design employed to evaluate the effectiveness of behavioural activation for 
depression in a 69-year old man at a specialist psychiatric unit for individuals with dementia. 
The fourth report presents a case study of a 38-year old man who was experiencing increased 
levels of anxiety. The assessment, formulation and intervention, all informed by the cognitive 
behavioural model, are described in addition to an evaluation of the intervention. The fifth 
report is the abstract of an orally presented case study describing the case of a 17-year old 
young woman with Anorexia Nervosa and low mood who was a patient at a specialist eating 
disorders unit. A cognitive behavioural intervention was implemented to target the cycle 
perpetuating her low mood. All names and identifying information in Volume II have been 
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THE LONGITUDINAL RELATIONSHIP BETWEEN DEPRESSIVE SYMPTOMS 





Background. There is evidence of an association between depressive symptoms and 
metabolic control in adolescents with Type 1 diabetes (T1D). Yet the directionality within this 
relationship is unclear. The current review aimed to synthesise longitudinal research to gain 
clarity regarding issues of directionality in addition to identifying factors that influence 
associations.  
 
Method. Embase, PsycINFO, MEDLINE, Web of Science and PubMed were searched using 
variations of the constructs related to the aims of this review (i.e. depression, T1D, metabolic 
control, adolescents, and longitudinal research). Suitability of research was assessed against 
inclusion and exclusion criteria and the quality of the included studies (n=14) was evaluated.  
 
Results. Most articles examined metabolic control in response to depressive symptoms. 
Findings were mixed with some studies suggesting a negative association between earlier 
depressive symptoms and subsequent metabolic control, an association that was reported to 
decrease over time. Furthermore, this relationship was not independent of the influence of 
other variables (e.g. illness specific factors, interpersonal factors). 
 
Conclusions. Directionality within the longitudinal relationship between depressive 
symptoms and metabolic control in adolescents with T1D remains unclear. Further research 
should consider influencing variables and more frequent follow-ups to facilitate a closer 
examination of longitudinal associations. 
 





Type 1 diabetes. Type 1 diabetes (T1D) is a metabolic illness caused by the 
destruction of insulin producing cells in the pancreas resulting in a permanent deficiency of 
insulin (American Diabetes Association, 2013). Approximately 26 500 children and young 
people in the UK have been diagnosed with this autoimmune disease (Diabetes UK, 2012), 
with numbers rising by an average of 3 – 4% per year across Europe (Patterson et al., 2012). 
Hypotheses for these increasing figures have predominantly focussed on environmental 
factors such as the surge in Vitamin D deficiency (Virtanen & Knip, 2003) and the lack of 
exposure to infections hindering the maturation of the immune system thus increasing 
susceptibility to developing autoimmune diseases (Gale, 2002). Irrespective of the possible 
causes, receiving a diagnosis of T1D during childhood and adolescence has lifelong 
implications including rigorous self-management through an often complex treatment plan. 
This self-care regimen typically involves a combination of the daily monitoring of blood 
glucose levels and regulating insulin with injections or an insulin pump, in addition to making 
comprehensive dietary and lifestyle changes (Silverstein et al., 2005). 
Metabolic control. Clinical treatment targets for individuals with T1D are based on 
achieving a level of blood glucose that is as close to normal levels, relative to age, and is 
assessed by examining metabolic control. Metabolic control is generally measured by 
calculating levels of glycosylated haemoglobin, also known as HbA1C (Rewers et al., 2009). 
HbA1c is the proportion of glucose molecules attached to haemoglobin in the blood and 
represents an average level of blood glucose over an eight to twelve week period. It has been 
reported as the most useful way of monitoring metabolic control (Saudek & Brick, 2009). It is 
recommended that children and adolescents attain HbA1c values of less than 7.5% (Rewers et 




young people are likely to struggle with meeting treatment goals, with a marked trend towards 
deterioration in HbA1c during adolescence (Bryden et al., 2001).  
Depression and Type 1 diabetes. Depression is a mood disorder characterised by the 
presence of symptoms including low mood, loss of interest in activities and feelings of 
worthlessness, in addition to changes in sleep, appetite and activity (American Psychiatric 
Association, 2013). The prevalence of depression is reported to be higher in individuals with 
T1D (Barnard, Skinner, & Peveler, 2006) and adolescents with T1D are particularly 
vulnerable to developing depressive symptoms (Grey, Whittemore, & Tamborlane, 2002). A 
higher prevalence of depression has been demonstrated within this sample compared to the 
general adolescent population (Kanner, Hamrin, & Grey, 2003) with incidence rates of up to a 
threefold occurrence (Johnson, Eiser, Young, Brierley, & Heller, 2013). These numbers are a 
cause for concern as young people with both T1D and depression are more likely to have 
suicidal ideation and, consequently, are at increased risk of suicide (Goldston, Kovacs, Ho, 
Parrone, & Stiffler, 1994). 
Numerous sequelae for adolescents with T1D and depressive symptoms (i.e. not 
reaching diagnostic criteria but displaying symptoms) have been identified. For instance, 
these young people are more likely to develop other psychiatric disorders including anxiety 
(Dantzer, Swendsen, Maurice-Tison, & Salamon, 2003) and eating disorders (Olmsted, 
Colton, Daneman, Rydall, & Rodin, 2008). The presence of depressive symptoms in this 
population has also been associated with poor adjustment to diagnosis and treatment demands 
(Lernmark, Persson, Fisher, & Rydelius, 1999) and reduced self-management which increases 
the risk of hospitalisation (Stewart, Rao, Emslie, Klein, & White, 2005).  
Depression and metabolic control. A number of hypotheses aim to explain the links 




theory attributes abnormalities in the functioning of the neuroendocrine system as a direct 
consequence of depressive symptoms. Musselman and colleagues (2003) suggest an excess of 
stress related hormones present in those with depression (e.g. cortisol) interfere with effective 
insulin functioning by further raising levels of blood glucose. More specifically, it is thought 
that the development of complications associated with depression and diabetes is caused by 
the effect depression has on metabolic control (de Groot, Anderson, Freedland, Clouse, & 
Lustman, 2001). The behavioural features of depression, e.g. reduced motivation, offer a 
plausible explanation for this as they result in poor self-management and compliance to 
treatment (Lin et al., 2004).  
Alternative hypotheses demonstrate the maladaptive self-perpetuating relationship 
between depression and metabolic control. A cycle has been identified where increased levels 
of HbA1c cause low mood related to not achieving treatment targets, which then creates 
further difficulties in achieving metabolic control goals by exacerbating behavioural 
symptoms and decreasing motivation to comply with treatment plans (Lustman & Clouse, 
2005). Cognitions specifically associated with depression are also thought to be a factor in 
this relationship. Farrell and colleagues (2004) found that an increase in depressive thinking 
styles was associated with an increase in general stress, resulting in higher levels of HbA1c in 
adolescents by impacting on self-management behaviour.  
The extant evidence base predominantly consists of cross-sectional research 
demonstrating that higher levels of depressive symptoms are associated with poorer metabolic 
control in adolescents with T1D (e.g. Hood et al., 2006; Kovacs et al., 1995; La Greca & 
Bearman, 2002). Existing reviews have further suggested factors that may influence this 
relationship at single time points. These include treatment compliance and the occurrence of 




neuropsychological factors and maternal depression (Kanner et al., 2003), and intrapersonal 
characteristics such as coping skills and self-efficacy (Neylon, O’Connell, Skinner, & 
Cameron, 2013). However, a significant gap identified in the literature is the need for more 
longitudinal research to clarify causal relationships (Delamater et al., 2001) and to further 
explore associations between depression and metabolic control over time (Grey et al., 2002).  
Aims. Adolescents with T1D are vulnerable to developing depressive symptoms. The 
current literature offers a more-or-less consistent picture with regard to associations between 
metabolic control and depressive symptoms, but there are mixed reports and theories as to the 
mechanisms of effect and directionality of results. The apparent lack of longitudinal studies 
within this area creates difficulty in drawing conclusions with confidence. Furthermore 
patterns over time in this association in adolescents remain a relative unknown. Building on 
the limitations identified in the literature, this review investigated the relationship between 
depressive symptoms and metabolic control in adolescents with T1D, with a particular focus 
on longitudinal research to help explore issues of directionality. Factors influencing this 
relationship in relation to longitudinal changes were identified. To determine the confidence 
in claims of identified associations, the quality of the research was assessed. A systematic 
review was therefore undertaken of the adolescent T1D evidence base with a focus on the 
following aims:  
(i) Identify findings in the literature regarding directionality in the longitudinal 
relationship between depressive symptoms and metabolic control. 
(ii) Identify factors in the literature that influence the relationship between 






 Search strategy. Five electronic databases (Embase, PsycINFO, MEDLINE, Web of 
Science, PubMed) were searched using variations of constructs related to the aims of the 
review, that is: depression, Type 1 diabetes, adolescents, longitudinal and metabolic control. 
Searches were conducted by combining variations using ‘AND’ as the Boolean operator. 
Variations of terms, entered in parentheses, were combined using ‘OR’ and truncation. Figure 
1 illustrates the variations of each construct and the application of Boolean operators. 
 
 
Figure 1. Variations of each construct entered in the search using Boolean operators. 
Databases were searched individually from their inception, as no other review of this 
nature had been done, to January 2014. The ‘Keyword’ searches of Embase, PsycINFO and 
MEDLINE resulted in 148, 33 and 99 articles respectively. The ‘Topic’ search of Web of 
































































































Science produced 83 articles and a search in ‘All Fields’ of PubMed resulted in 188 articles. 
The total number of articles (including duplicates) retrieved from the five databases was 551.  
 Inclusion and exclusion criteria. After the removal of 229 duplicate articles across 
the databases, the abstracts of articles were scanned against inclusion criteria to determine 
their relevance. To ensure the most appropriate research was included, and as some abstracts 
did not clearly evidence the criteria for inclusion, exclusion criteria were applied to the full 
texts of the remaining articles. Bibliographies of included articles were examined but yielded 
no further results. The inclusion and exclusion criteria are detailed in Table 1.   
 
Table 1 
Criteria for inclusion and exclusion. 
Inclusion criteria Exclusion criteria 
 Adolescents aged between 8 and 18 
years of age 
 Findings were based on a sample that 
consisted of participants with T1D in 
addition to participants with other health 
chronic conditions e.g. asthma  
 Diagnosis of T1D   Age range of the sample at baseline was 
below 8-years and exceeded 18-years of 
age* 
 Metabolic control data included  HbA1c data not reported 
 Depressive symptoms were assessed  No assessment of depressive 
symptomatology 
 Associations between depression and 
HbA1c were examined over time with 
at least one follow up 
 Depression and HbA1c were assessed at 
only one time point 
 Published in English in a peer-
reviewed journal, describing empirical 
research  
 Direct association between depression and 
metabolic control was not explored or 
when depression was not entered as the 
independent variable when HbA1C was 
the dependent variable, and vice versa 
*Limiting studies to omit those where the samples were over 18 years of age at follow-up but not at baseline 
would have excluded two papers (Kovacs et al., 1996; Northam et al., 2004) that followed the adolescent 





 Final selection. Application of the inclusion criteria, removal of duplicates and 
examination of full texts using the exclusion criteria resulted in 14 articles. Figure 2 illustrates 
the number of articles excluded at each stage of the screening process.  
Figure 2. Illustration of the screening process (adapted from Moher et al., 2009). 
Search of keyword, topic or all fields: 
((depress* OR mood OR wellbeing) AND diabetes AND (type 1 OR insulin 
dependent OR IDDM) AND (adolescen* OR child*) AND (longitudinal* 
OR predict* OR follow up) AND (metabolic control OR glycemic control 
OR glycosylated haemoglobin OR glucose regulation OR management OR 
blood glucose monitoring OR BGM OR HbA1c OR adher* OR regimen)) 
 
Databases Selected:  










Total number of articles identified 
through search 
n = 551 
Number of titles and abstracts screened 
































































Number of duplicates removed 
n = 229 
Articles excluded  
n = 251 
Not English (20) 
Not empirical research (68) 
Not adolescent (76) 
Not T1D (49) 
Not longitudinal (10) 
No depression measure (15) 
No HbA1c measure (0) 
Irrelevant (13) 
 
Number of full texts screened 
n = 71 
Articles excluded  
n =57 
Not adolescent (14) 
Not T1D (0) 
Not longitudinal (11) 
No depression measure (10) 
No HbA1c measure (4) 
Not exploring relationship 
between depression and 
HbA1c (18) 
 
Number of articles meeting inclusion 
for review 




Quality assessment. The quality of the final subset of articles was assessed using a 
formal critical appraisal tool. The ‘Checklist for Measuring Study Quality’ (Downs & Black,  
1998) was developed for evaluating a range of research studies. Certain items were not 
applicable to the research methods employed in the reviewed articles, particularly items 
concerning interventions. Consequently 12 items
1
 were removed to produce an alternative 
quality score incorporating appropriate items to facilitate quality comparison across studies. 
The item regarding power (no. 27) was re-worded to increase its relevance to the review. 
Justification for the adoption of this framework is provided in Figure 3. 
 
Figure 3. Justification for selection of The Checklist for Measuring Study Quality  
 
 Data extraction. Data from articles were extracted and tabulated to provide a 
framework for the review. The first table (Appendix A) addressed the aim of directionality in 
the longitudinal relationship between depressive symptoms and metabolic control. The second 
table (Appendix B) focussed on variables reported to influence this relationship.
                                                          
1
 The items removed as numbered on the original tool (Appendix C) were: 4, 5, 8, 14, 15, 17, 19, 21, 22, 23, 24, 
25. 
Evidence for selecting the Checklist for Measuring Study Quality (Downs & Black, 1998) 
 The tool was designed for use in the process of appraising research with various 
methodologies in systematic reviews. 
 The final revised checklist demonstrated good test-retest reliability and inter-rater 
reliability (Downs & Black, 1998).  
 A systematic review exploring tools used to assess risk of bias in research studies 
concluded that the Downs and Black checklist was one of two deemed the most useful 
out of 14 tools from 182 tools identified in the literature (Deeks et al., 2003). It was 
commended for providing individual profile scores including quality of reporting, 
internal and external validity, and power as well as the overall quality scores.  
 A separate systematic review of appraisal tools found that from the 21 scales identified, 
the Downs and Black checklist was the only tool that had reported internal consistency 
(Olivo et al., 2008).  
 The checklist has been recommended for its acceptable to good inter-rater reliability 
(Jarde, Losilla, & Vives, 2012).   
 The tool has been used in other systematic reviews within the area of diabetes in young 






 Study aims. Of the 14 papers included for review, two examined the relationship 
between earlier levels of metabolic control and later depressive symptoms. The remaining 12 
studies explored the converse. Differences emerged in terms of primary aims and how the 
relationship of interest was explored e.g. through direct analysis or via predictor models. An 
overview of the aims is provided in Figure 4. 
Figure 4. Overview of the aims of studies included for review. 
 
 Assessment of depressive symptoms. The majority of the studies (n = 11) used the 
Children’s Depression Inventory (CDI) or variations of the tool (Kovacs 1985, 1992, 2001, 
2003). Three studies used cut off scores
2
 on the CDI to describe the number of participants 
with clinical levels of depressive symptoms, one of which reported analyses on both cut-off 
                                                          
2
 Scores higher than or equal to 13 on the CDI suggest depressive symptoms that are clinically significant. 
Aims of reviewed studies  
 In terms of the impact of previous outcomes of metabolic control predicting later depressive 
symptoms, one study explored whether a history of poor metabolic control was associated with 
current psychiatric status (Northam et al., 2004) whereas another utilised HbA1c as a predictor 
of psychological functioning at follow-up (Kovacs et al., 1990).  
 Of the remaining 12 studies, eight described associations between baseline depressive 
symptoms and HbA1c at follow-up (Colton et al., 2013; Helgeson et el., 2009; Hilliard et al., 
2011; Hilliard et al., 2013; Hood, Rausch & Dolan, 2011; Kovacs et al., 1996; McGrady & 
Hood, 2010; Wu et al., 2013). Six of these stated the primary aim was to explore this 
relationship over time (Colton et al., 2013; Helgeson et el., 2009; Hilliard et al., 2011; Hood, 
Rausch & Dolan, 2011; Kovacs et al., 1996; McGrady & Hood, 2010), some also explored 
interactions between depressive symptoms and/or HbA1c with other variables i.e. blood 
glucose monitoring (BGM; McGrady & Hood, 2010; Hood, Rausch & Dolan, 2011; Hilliard et 
al., 2011; Helgeson et el., 2009) and disturbed eating behaviour (Colton et al., 2013).  
 Although not the primary aim two studies reported results on the relationship of interest. One 
aimed to describe the effects of depressive symptoms on parental involvement to predict 
HbA1c through BGM as a mediator (Wu et al., 2013) whilst the other identified trajectories of 
HbA1c over time, exploring variables that predicted membership to subgroups (Hilliard et al., 
2013). Similarly one other paper identified trajectories of HbA1c however depressive 
symptoms were entered as part of a model with other predictor variables (Helgeson et al., 
2010). Two more papers explored this relationship with depressive symptoms entered in to 
models of predictor variables (Guilfoyle et al., 2011; Ingerski et al., 2010) whilst another 
examined depressive symptoms as a moderator to explore their effect on the relationship 




scores and continuous scores. The remaining studies explored the variance in continuous CDI 
scores. Parental reports of adolescent depressive symptoms were assessed using the parent 
version of the CDI (CDI:P; Kovacs, 1992) in one study. In addition to using the CDI, one 
study also used the Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS; 
Kaufman et al., 1997). Other methods of assessing depressive symptoms were based on 
diagnostic criteria, with one study using the Interview Schedule for Children and Adolescents 
(Kovacs, 1985) followed by consensus of diagnosis amongst researchers. A diagnostic 
method, the Diagnostic Interview for Children and Adolescents-IV (Herjanic & Reich, 1997), 
was also used in another study at follow-up with the Child-Behaviour Checklist (Achenbach, 
1991) at baseline. Table 2 provides a summary of the assessment methods used. 
 
Table 2  
Methods of assessment for depressive symptoms utilised across the reviewed studies. 
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Children’s Depression Inventory 
- Continuous score 
√   √ √ √ √  √ √  √ √ √
P 
Children’s Depression Inventory 
- Cut off score 
       √  √ √    
Kiddie-Schedule for Affective 
Disorders and Schizophrenia 
           √   
Interview Schedule for Children 
and Adolescents 
 √             
Diagnostic Interview for 
Children and Adolescents-IV 
  √            




 With regard to clinical application, the consideration of cut-off scores or continuous 
scores is dependent on the primary purpose of the assessment. Whilst cut-off scores 
demonstrate clinical levels of depression according to diagnostic criteria, continuous scores 
demonstrate the severity and level of depressive symptoms experienced.  
 Study duration. The reported study duration ranged from 3-months to those that 
assessed participants over a period of 10-years. Similarly, the number of follow-ups 
conducted varied between the studies. Table 3 provides a summary of the number of follow-
ups over the study duration reported in each article and demonstrates that most of the studies 
with fewer follow-up assessments were those with a relatively short study duration. Eight 
studies reported results on multiple follow-ups. However, despite a longer study duration of 
5-years, Colton and colleagues (2013) only conducted one follow-up assessment. Other 
studies failed to clearly report how many follow-ups were conducted. 
 
Table 3  
 
Study duration and number of follow-ups (in ascending order of study duration). 
M = Months; Y = Years; U = Unclear 
*Average study duration 
**Every 3 months 
 
 Quality assessment. The scores from the critical appraisal tool are presented in Table 














































































































































































































Study Duration 3M 6M 6M 6M 12M 18M 
18- 
24M 
4Y 5Y 5Y 5Y 6Y 8.6Y* 10Y 




articles revealed that most of the papers provided sufficient information with regard to the 
reporting of the research conducted. One paper (McGrady & Hood, 2010) did not clearly 
describe the main aims of the study. Most discrepancies between the scores were a 
consequence of failing to report exact probability values. With regard to external validity, all 
papers were similar however only one study (Northam et al., 2004) described a sample that 
was representative of the population they were recruited from thus increasing the generality of 
the findings. Samples in the other studies were skewed in terms of ethnicity. All studies 
demonstrated good internal validity based on the measures used and the statistical analyses 
conducted. Five papers did not make reference to power when reporting significant findings. 
The paper by McGrady and Hood (2010) scored relatively lower than the other papers, 
however the areas in which points were not awarded were not deemed as being critical to the 
credibility of the findings. The main limitation established across the literature was 
concerning the external validity of findings. This was not applicable to the paper by Northam 
and colleagues (2004) which rated similarly to other papers with a score of 14, only losing a 
mark for failing to report exact probability values. Therefore on the basis of a greater 
generality and applicability of findings to the wider population, this paper was considered as 
the strongest from those reviewed. 
Overall, the quality of the papers was broadly similar as they rated fairly highly with 
scores suggesting no need for exclusion from this review based on quality. The papers will be 
discussed accordingly, referring to issues of quality based on the outcome of the critical 
appraisal tool, with regard to the aims of the review, that is: (i) Identify findings in the 
literature regarding directionality in the longitudinal relationship between depressive 
symptoms and metabolic control; and (ii) Identify factors in the literature that influence the 





















































































































































































































Reporting (Yes = 1; No = 0)               
1. Is the hypothesis/aim/objective of the study clearly described?  
 
1 1 1 1 1 1 1 0 1 1 1 1 1 1 
2. Are the main outcomes to be measured clearly described in the Introduction or 
Methods section? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3. Are the characteristics of the patients included in the study clearly described?  
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6. Are the main findings of the study clearly described? 
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7. Does the study provide estimates of the random variability in the data for the main 
outcomes? 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9. Have the characteristics of patients lost to follow-up been described? 
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the 
main outcomes except where the probability value is less than 0.001?  
1 1 0 1 0 1 0 0 1 1 1 1 0 1 
External Validity (Yes = 1; No/Unable to determine = 0)               
11. Were the subjects asked to participate in the study representative of the entire 
population from which they were recruited?  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12. Were those subjects who were prepared to participate representative of the entire 
population from which they were recruited?  
0 0 1 0 0 0 0 0 0 0 0 0 0 0 
13. Were the staff, places, and facilities where the patients were treated, representative 
of the treatment the majority of patients receive?  





















































































































































































































Internal validity – bias (Yes = 1; No/Unable to determine = 0)               
16. If any of the results of the study were based on “data dredging”, was this made 
clear? 
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
18. Were the statistical tests used to assess the main outcomes appropriate?  
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
20. Were the main outcome measures used accurate (valid and reliable)? 
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Internal validity – confounding (selection bias) (Yes = 1; No/Unable to determine = 
0) 
              
26. Were losses of patients to follow-up taken into account? 
 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Power (Yes = 1; No/Unable to determine = 0)               
27. Did the study report consideration of power to report clinical significant effects? 1 0 1 1 1 1 1 0 0 0 0 1 1 1 




(i) Identify findings in the literature regarding directionality in the longitudinal 
relationship between depressive symptoms and metabolic control. Articles reporting 
associations between earlier depressive symptoms and later HbA1c values (n=12) will be 
discussed first. They will be grouped into those reporting a direct statistical analysis between 
metabolic control and depressive symptoms (n=6) or a diagnosis of depression (n=2), where 
depressive symptoms were included as a predictor of metabolic control subgroup membership 
(n=3) or entered into a model alongside other predictor variables (n=4). Articles may be 
described under multiple headings where relevant. Articles describing associations between 
previous HbA1c values with later depressive status (n=2) will be discussed with regard to 
results that either reported depressive symptoms (n=1) or a diagnosis of depression (n=1).  
Metabolic control measured in response to depressive symptoms: Direct analysis. Of 
the six studies that aimed to explore the direct relationship between depressive symptoms and 
HbA1c, two described results over a 6-month period. Hood, Rausch and Dolan (2011) 
explored this relationship with a focus on change scores from baseline to follow-up. The 
results of the general linear model showed that an increase in depressive symptoms over time 
was associated with increasing levels of HbA1c (p<0.001). More specifically, an increase of 
one point from baseline to follow-up on the CDI was associated with a 0.11% increase in 
HbA1c. However, McGrady & Hood (2010) reported no significant association between 
depressive symptoms and metabolic control despite 23% of the sample reporting clinically 
significant depressive symptoms on the CDI. An analysis using individual subscales of the 
CDI further failed to demonstrate significant associations with HbA1c. Discrepancies between 
results may be due to Hood and colleagues utilising change scores to determine associations 
as opposed to the follow-up scores reported by McGrady and Hood. With regard to bias, 




colleagues provided a clearer account of their findings and also stated details of an unplanned, 
exploratory analysis (i.e. data dredging). However it was unclear whether power was 
considered when describing findings. Both papers reported that results were based on a 
homogenous sample in terms of being predominantly White American, raising caution with 
regard to issues of generalisability. McGrady and Hood further questioned the use of self-
report measures to assess depressive symptoms.  
Despite higher HbA1c being associated with increased depressive symptoms at 
baseline, Hilliard et al. (2011) reported that baseline depressive symptoms were not associated 
with HbA1c at 12-months. A strength of this paper was the analyses of both cut-off scores 
and continuous scores on the CDI. In contrast to these results, Helgeson and colleagues 
(2009) found that baseline depressive symptoms predicted increases (B=1.18, p<0.01) and 
changes (B=-0.71, p<0.05) in HbA1c at 12-months. Despite annual assessments over a 4-year 
period the predictive ability of depressive symptoms decreased over time, with the strongest 
predictive value at baseline for HbA1c at 12-months. The account of internal consistency for 
the CDI at each assessment point increased the internal validity of the study. Both papers 
described limitations with regard to sample characteristics and the use of predominantly 
White American participants. The main difference between the articles was that power was 
explicitly considered in the Helgeson paper.  
Where the relationship between depressive symptoms and HbA1c was not the main 
aim of the study, Wu and colleagues (2013) found that self-reports of depressive symptoms at 
baseline were not associated with HbA1c at 18-months, however, parental reports of child 
depressive symptoms were significant (p=0.008). The use of reports from carers in addition to 
self-report was highlighted as a methodological strength. Limitations included the lack of a 




based in the USA, with treatments and practices specific to the target recruitment clinic, can 
in fact be generalised to other contexts and cultures.  
In a study exploring the relationship between depression and disturbed eating 
behaviour on metabolic control, Colton and colleagues (2013) reported that depressive 
symptoms measured at baseline did not predict metabolic control at 5-years. However results 
were based on a female sample and the authors stated that the relatively small sample size has 
implications for the power of the study. A strong retention rate was noted as a strength, with 
no losses at follow-up, in addition to the use of standardised diagnostic interviews for 
depression alongside questionnaires.  
In summary, when based on baseline CDI scores (as opposed to change scores), 
results demonstrate a significant association between depressive symptoms and HbA1c at 6-
months. No significant associations at 12-months were reported when using cut-off scores and 
continuous scores. Conversely the predictive value of baseline depressive symptoms was 
significant at 12-months but decreased over time. Differences in results emerged through 
administration of self and parental reports of child depressive symptoms. The latter 
demonstrated an association between earlier depressive symptoms and HbA1c at follow up. 
Association ceased to exist over longer follow-up periods of up to 5-years with no significant 
results reported. Overall, earlier symptoms of depression appeared to be associated with 
poorer metabolic control, with this association decreasing over time. 
Metabolic control measured in response to a diagnosis of depression: Direct 
analysis. Two studies described the direct relationship between a diagnosis of depression and 
HbA1c. The study by Colton and others (2013) described above reported that a history of 
depression over a 5-year period or current diagnosis was not associated with poorer metabolic 




size (n=30 history or diagnosis of depression; n=68 no history or diagnosis). Kovacs and 
colleagues (1996) reported similar findings where a diagnosis of major depressive disorder 
had no significant longitudinal association with HbA1c over an average period of 8-years. 
The authors suggested that depressive symptoms elicit caring behaviours from carers who 
then support the young person with diabetes self-care tasks, hence serving as a protective 
factor for metabolic control. However a measure of parental/carer involvement was not 
implemented to assess this formally. Diagnostic status was monitored throughout the study 
however, similar to Colton et al., a relatively small number (n=24) had a diagnosis.  
In summary, a current or previous diagnosis of depression does not appear to be 
associated with HbA1c over a longer period of up to 10-years. However findings are based on 
small sample sizes thus reducing power and risking a type 2 error. 
Membership to metabolic control subgroup as predicted by depressive symptoms. Of 
the three studies describing whether depressive symptoms predicted membership to a 
subgroup of metabolic control, Hilliard and colleagues (2013) identified subgroups using data 
from trajectories over 24-months. Participants belonged to one of three subgroups identified 
as: meeting treatment targets, normatively similar (HbA1c moderately out of range), and high 
risk (HbA1c severely deviant from targets). Higher levels of depressive symptoms at baseline 
significantly predicted membership of the ‘normatively similar’ subgroup at 18 – 24 months 
compared to membership of the meeting treatment targets group (p<0.05), but not to the high 
risk group. However negative emotions specifically related to blood glucose values as 
measured by the Blood Glucose Monitoring Communication Questionnaire (Hood, Butler, 
Volkening, Anderson, & Laffel, 2004) predicted membership to the high risk group compared 
to the meeting treatment targets group. According to the trajectories, membership of 




inconsistent with previous findings where deteriorations over time were noted, thus attributing 
their findings to a shorter follow-up period compared to previous studies. The authors note 
that the diverse HbA1c values of the sample provide an accurate representation of the wider 
population. On the other hand they comment that the sociodemographic characteristics of the 
sample do not reflect those of the population from which they were recruited as those who 
participated were predominantly White American, with minority groups being proportionally 
under-represented.  
In a study identifying trajectories of HbA1c over 5-years, Helegson et al. (2010) 
reported that depressive symptoms at baseline were not found to influence membership to the 
two trajectories identified (‘stable/good control’ and ‘poor control’). Negative emotions 
related to diabetes increased the risk of membership to the ‘poor control’ group however this 
was based on a single item developed by the researchers and not a standardised questionnaire. 
The authors acknowledged the possibility of identifying additional trajectories however 
fluctuations in HbA1c prevented this. In comparison to the other articles reviewed, the authors 
do not provide participant characteristic data (demographic and diabetes specific) but instead 
refer readers to the original paper on which the follow-up is based. Despite collecting data 
over a period of 5-years, changes in the variables overtime, including depressive symptoms, 
were not reported and this was recognised as a limitation in addition to the lack of ethnic 
diversity within the sample.  
In predicting membership to a metabolic control subgroup (‘good control’, ‘poor 
control’ or ‘hypoglycaemia only’), baseline parental reports of internalising behaviour 
including depressive symptoms were not found by Northam and others (2004) to be 
associated with metabolic control over a period of 10-years. The paper provided a scarce 




(e.g. marital status of caregiver). Of the studies described in this review, this study used a 
relatively small sample however participants were reported to be representative of the target 
population. Data were described over the longest follow-up period, which has disadvantages 
in terms of attrition rates; therefore the paper can be praised for a clear comparison of results 
between participants lost at follow-up. 
 In summary, at 24-months higher levels of baseline depressive symptoms were 
associated with subgroup membership where metabolic control was moderately out of range 
but not high risk. This could suggest that depressive symptoms have a relatively mild effect 
on HbA1c over time whereas diabetes specific negative emotions, assessed using formal and 
informal measures, are associated with a more severe effect on metabolic control. 
Associations ceased to exist at later follow-ups however these were based on parental reports 
and where fewer trajectories were identified. 
Metabolic control measured in response to depressive symptoms as part of predictor 
model(s). Four studies described models of variables including depressive symptoms to 
predict HbA1c. As these studies describe the influence of additional variables, the findings are 
more relevant to be discussed with regard to the second aim of this review.  
Depressive symptoms or diagnosis of depression explored in response to metabolic 
control. In a study aiming to identify predictors of psychological adjustment to T1D, Kovacs 
and colleagues (1990) found no significant association between metabolic control and 
depressive symptoms over a 6-year period. However, follow-up intervals were irregular, 
which the authors attribute to logistical difficulties. The paper can be praised for a detailed 
description of the sample, including documentation of cognitive ability, and for providing 
information on participants who withdrew from the study. Average CDI scores at each 




follow-up and demonstrated relatively small numbers at the final follow-up (n=24). Similar to 
the other articles reviewed, the sample was not representative of the wider target population. 
Northam and colleagues (2004) reported no significant association between HbA1c 
scores over 10-years and a psychiatric diagnosis (including mood disorder) at the 10-year 
follow-up. However ‘mood disorder’ included major depressive disorder in addition to other 
mood related diagnoses (Dysthymia and Mania/Hypomania). The authors do not provide 
details on how many were diagnosed with individual disorders or how changes in HbA1c may 
have been associated with mood/depressive symptoms. Assessing pre-existing emotional 
difficulties and also following a cohort of participants from diagnosis of T1D is a strength of 
the study. The authors recognise weaknesses with regard to a small sample size resulting in 
limited statistical power.  
In summary, historical HbA1c values are not associated with later outcomes of 
depressive symptoms or a diagnosis of depression. However, these findings are based on a 
limited number of papers that reported findings on small sample sizes. 
(ii) Identify factors in the literature that influence the relationship between 
depressive symptoms and metabolic control over time. Articles exploring the influence of 
additional variables including depressive symptoms on metabolic control over time will be 
discussed (n=9). All articles investigated the impact of historical depressive symptoms on 
later values of HbA1c. Articles will be discussed in respect to whether depressive symptoms 
were entered alongside other variables in predictor models of HbA1c (n=6) or whether 
mediating and moderating variables were explored within the longitudinal relationship 
between depressive symptoms and HbA1c (n=3). 
Metabolic control measured in response to depressive symptoms as part of predictor 




monitoring (BGM), Guilfoyle and colleagues (2011) reported that depressive symptoms 
significantly predicted HbA1c at 3-months (p<0.05) and accounted for 4.76% of the variance 
in HbA1c scores (p<0.01). BGM frequencies, as reported by carers, accounted for 13.42%. 
The use of objective reports of BGM (i.e. carer reports) was recognised as a limitation 
although the difficulties with using BGM meter data was acknowledged. This study can be 
praised for describing a sub-sample used in some of the analyses who had complete data from 
BGM meters (n=90). It is also one of the few papers in this review to clearly state conducting 
post hoc analyses. However results were based on the shortest follow-up period from the 
reviewed studies (3-months). As HbA1c values reflect the past 8 – 12 weeks, conclusions 
regarding the predictive value of depressive symptoms for HbA1c over time based on these 
results should therefore be made with caution. 
 In a regression model predicting HbA1c at 12-months, Hilliard and colleagues (2011) 
found that depressive symptoms were not a significant predictor of HbA1c but did 
significantly predict BGM. This was explained in terms of the behavioural features of 
depression (e.g. poor motivation, lethargy) hindering the upkeep of self-management tasks. It 
is of interest that those who reported higher depressive symptoms at baseline received more 
visits from mental health professionals. When the number of visits was added to the model, 
depressive symptoms no longer predicted BGM at 12-months suggesting that psychological 
treatment to reduce depressive symptoms increased self-management as measured by BGM.  
 Ingerski and others (2010) found that after controlling for demographic and disease 
specific variables, the regression model of baseline depressive symptoms was not found to be 
a significant predictor of HbA1c at 6-months. Significant predictors of HbA1c at 6-months 
included adolescent reports of insulin delivery mode (B=-0.21, p<0.05), duration of illness 




family conflict. Again a limitation of this study is with regard to the participants with the 
authors highlighting the predominantly white, female sample from high functioning families. 
They also acknowledge the influence of social desirability as a risk of bias from families. A 
strength of the paper is the description of the characteristics of the sample both at baseline and 
follow-up.   
Depressive symptoms were described as being “marginally significant” (p. 263) by 
Helgeson and others (2009) in predicting HbA1c over 4-years. However this association was 
influenced by other variables including bulimic symptoms (B=0.27, p=0.01), body mass index 
at baseline (B=0.04, p=0.01) and negative relationships with peers (B=0.35, p=0.01). In terms 
of the latter, negative relationships with friends also predicted changes in HbA1c over time 
(B=0.49, p<0.001). These findings were discussed with regard to the distress associated with 
turbulent peer relationships negating from self-care behaviours. The authors concluded that 
the model suggests the association between HbA1c and depressive symptoms over time is not 
independent from the influence of other factors.  
 In another study exploring eating disorders, Colton and colleagues (2013) found that 
after controlling for BMI at 5-years and duration of T1D, a multiple regression model 
revealed that CDI scores and eating disorder related psychopathology did not predict HbA1c 
at 5-years. Disturbed eating behaviour was associated with depressive symptoms but not 
HbA1c. The differences in these results and those reported by Helgeson and others (2009) 
may be associated with Colton’s study including a range of eating disorders as opposed 
focussing solely on bulimia. 
 A logistic regression model by Hilliard et al. (2013) of demographic, psychological 
and family predictor variables demonstrated a number of factors predicted membership to 




severely out of range throughout the study duration were associated with negative emotions 
specifically related to blood glucose values as measured by the Blood Glucose Monitoring 
Communication Questionnaire (BGMCQ; Hood et al., 2004). These diabetes specific negative 
emotions predicted membership to the high risk group over the meeting treatment targets 
group whereas higher depressive symptoms predicted membership of the normatively similar 
group compared to the meeting treatment targets group. Diabetes specific family conflict also 
predicted this in addition to predicting HbA1c levels that were severely deviant from the 
target range (p<0.01). Separate assessment of diabetes specific distress is a clear strength of 
this study. 
In summary, the literature suggests that depressive symptoms are not exclusive of 
other variables in their involvement in HbA1c outcomes at follow-up. From the literature 
reviewed, the variables that were found to be part of significant models were mostly 
associated to diabetes specific factors, particularly with regard to self-care i.e. frequency of 
BGM and negative emotions related to self-care. There also appears to be some suggestion for 
the role of other disorders (eating disorders) as well as systemic and relational influences on 
metabolic control. 
Metabolic control measured in response to the influence of mediator/moderator 
variables. Wu and colleagues (2013) entered the frequency of BGM at 12-months as a 
mediator of the relationship between depressive symptoms and parental involvement to 
predict HbA1c. Findings suggested that parental reports of adolescent depressive symptoms at 
baseline influenced the relationship between adolescent perceptions of parental involvement 
as reported at baseline (measured using the Diabetes Family Responsibility Questionnaire; 
Anderson et al., 1990) and BGM to impact on HbA1c at 18-months. However the influence of 




significant when fewer symptoms of depression were reported on the CDI (less than or equal 
to 6). As self-reports of depressive symptoms were not associated with HbA1c at follow-up 
there may be a suggestion that parental perceptions of the child and the nature of the 
caregiver-child relationship is a factor to consider when interpreting results. Obtaining child 
and parental reports was reported as a strength of the study however no comment was made 
on the discrepancy between the two reports of depressive symptoms. 
In a post-hoc analysis Hood, Rausch and Dolan (2011) found that the interactions 
between contextual variables and CDI change scores were not moderators of change in 
HbA1c over time. However as depressive symptoms increased, higher frequencies of BGM at 
baseline moderated the effect of depressive symptoms on HbA1c. The positive influence of 
BGM reduced the risk of raised HbA1c levels. The authors comment on the protective role of 
BGM as an indicator of self-care levels in reducing the effects of depressive symptoms on 
HbA1c over time. Conversely, a decrease in BGM results in depressive symptoms having a 
greater effect, causing HbA1c levels to increase. The interaction between the variables was 
demonstrated with baseline HbA1c levels interacting with baseline BGM and change in CDI 
to predict change in HbA1c over time (p<0.001).   
In a study examining the effects of stressful life events on HbA1c over a period of 5-
years, Helgeson, Escobar et al. (2010) found that depressive symptoms were associated with 
metabolic control over time (p<0.05). However this association was only reported when the 
depressive symptoms were predicted by stressful life events. Depressive symptoms were not 
identified as a significant mediator in the relationship between stressful life events and 
metabolic control. An association was identified between BGM and metabolic control over 
time when stressful life events predicted BGM. However BGM was not found to be 




raise caution to the generality of findings due to the relatively homogenous sample not 
representing the ethnic diversity of the target population. They also comment on how results 
based on annual assessments may be a limitation.    
 In summary, the relationship and interactions between BGM and depressive symptoms 
appear to have an impact on HbA1c over time. There is also evidence regarding external 
stressors exacerbating depressive symptoms to influence HbA1c. 
Discussion 
 This review explored the evidence base for the longitudinal relationship between 
depressive symptoms and metabolic control in adolescents with T1D. Literature was reviewed 
and discussed in terms of findings regarding directionality in the associations between 
depressive symptoms and metabolic control and identifying factors that have a significant 
influence on this relationship.   
 Directionality in the longitudinal relationship between depressive symptoms and 
metabolic control. With regard to clarification on issues of directionality, the literature 
revealed mixed results. Where later depressive symptoms or depression status was explored in 
response to earlier HbA1c values, no significant results were identified. However this was 
based on a small number of articles (n=2). The majority of the papers identified in this review 
explored historical depressive symptoms and later values of metabolic control, again 
revealing mixed findings. There was some support for associations between depressive 
symptoms at baseline and metabolic control at follow-up (e.g. Wu et al., 2013; Hilliard et al., 
2013) however there was evidence that these associations decrease over time. For example, it 
was suggested that the predictive value of depressive symptoms on HbA1c is limited to earlier 
follow-ups, decreasing after a year (Helgeson et al., 2009). Conversely, results describing 




The main conclusions regarding significant associations were attributed to the behavioural 
symptoms of depression with lack of motivation creating a barrier to self-care and thus 
resulting in poor metabolic control. It was interesting to note that negative emotions 
specifically related to T1D were found to have a greater impact on metabolic control than 
depressive symptoms (Hilliard et al., 2013). This suggests that metabolic control may be 
influenced to a greater or lesser extent depending on the cause of distress.  
 The inconsistent findings are possibly the result of differences in design, such as 
variations in the method of assessing depressive symptoms. Similarly, differences emerged 
where metabolic control was grouped into categories representing the degree of control (e.g. 
good control, poor control) or where HbA1c and changes in values were described. 
Furthermore variances in terms of study duration and number of follow-ups conducted 
prevented direct comparison between studies. 
 Factors influencing the longitudinal relationship between depressive symptoms 
and metabolic control. Disturbed eating behaviour, relational issues with caregivers and 
stressful life events were found to be involved in the relationship between depressive 
symptoms and metabolic control. The extent of their influence varied and was not consistent 
across the articles reviewed. The factor that appeared to be most common in influencing the 
relationship of interest across the literature was BGM, including negative emotions related to 
BGM. The reported capacity of its influence varied. For example, there was support for BGM 
as a moderator between depressive symptoms and HbA1c where depressive symptoms were 
found to predict BGM, which in turn would influence HbA1c values. Decreased BGM 
appeared to be the result of decreased motivation levels, a common symptom of depression. 
However, much of the research in this review only explored associations up to 12-months 




of BGM was not independent of external factors such as stressful life events, family conflict 
and parental involvement (Guilfoyle et al., 2011). 
 The findings regarding BGM appear to be mixed and demonstrate the complex 
interactions between BGM, depressive symptoms and additional factors on metabolic control. 
The protective role of BGM within the relationship was highlighted and was consistent with 
previous research, where increased BGM leads to increased levels of HbA1c (Hood, Peterson, 
Rohan, & Drotar, 2009). In a previous review, Borus and Laffel (2010) identified factors in 
addition to depression that may impact on HbA1c by influencing self-care. These included 
non-modifiable variables such as age, gender and illness duration, and modifiable factors such 
as the role of peers and family. Not all of these factors were identified in the current review, 
which again may reflect the limited number of articles reviewed. 
 Limitations. Limitations of the reviewed research were similar to those noted in other 
systematic reviews within T1D. For example, Barnard, Skinner and Peveler (2006) 
commented on the lack of control groups increasing the risk of recruitment bias as those 
consenting may be doing so in the hope that it will be beneficial for their treatment. The 
absence of groups for comparison purposes also increases the difficulty in explicating whether 
the associations found would be dissimilar to children with depressive symptoms but without 
T1D, thus reducing the generality of the findings. 
The overall quality of the literature was not a concern however the similar scores on 
the critical appraisal tool for outcome measures and the sample could be associated with 
papers reporting data from the same sample in prospective studies. Also with regard to 
participants, the majority of papers reported limitations in terms of having samples that were 
not representative of the population from which they were recruited, limiting the applicability 




limiting the power of studies. Furthermore, the adolescent period comes with its own 
demands, independent of T1D. These challenges include hormonal and emotional changes, 
developing a sense of self and becoming more independent and autonomous (Cameron, 2006; 
Grey et al., 2002). However these factors were not acknowledged in the reviewed articles. 
 In terms of the measures used, all of the studies utilised HbA1c as an indicator of 
metabolic control, however Hilliard et al. (2013) comment that HbA1c fails to reflect more 
severe difficulties such as hyper- and hypoglycaemia. The self-report measures of depressive 
symptoms were validated for use within the adolescent population yet formal assessment by 
clinicians may have provided more comprehensive information (McGrady & Hood, 2010). 
  Despite being longitudinal in the sense of monitoring changes over time, a number of 
studies reported results over a short follow-up period (e.g Guilfoyle et al., 2011; McGrady & 
Hood, 2010). Where longer follow-up periods were reported, results and changes over time 
were not fully described (Helgeson et al., 2010), possibly risking the discovery of patterns and 
associations. 
 Implications for clinical practice and research. Despite the outcomes of this review 
presenting mixed results, the vulnerability of the target population was evident. In line with 
implications from previous research (e.g. McGrady, Laffel, Drotar, Repaske, & Hood, 2009; 
Stewart, Rao, & White, 2005) and the recommendations in the reviewed papers, the current 
review suggests the need for assessment, regular monitoring and consequent treatment of 
depressive symptoms in adolescents with T1D. The aim would be to reduce the negative 
influence of depressive symptoms on diabetes related outcomes, including self-care and 
BGM. Hilliard and colleagues (2011) emphasise how screening questionnaires can take as 




 Early screening of emotional difficulties and additional problems (e.g. disturbed eating 
behaviour) is recommended to prevent further difficulties (Colton et al., 2013). The 
administration of parental reports of adolescent emotional functioning alongside adolescent 
self-reports will facilitate the identification of difficulties that might be missed or not 
disclosed by the adolescent. Additionally, the use of continuous scores as opposed to cut-off 
scores is recommended to ensure that underlying difficulties are not overlooked (Hilliard, 
Herzer et al., 2011) as even mild symptoms of emotional distress affect the ability to adapt to 
T1D (Kovacs et al., 1990). Aside from screening for depressive symptoms, monitoring and 
encouraging discussions regarding the impact of stress on T1D by healthcare professionals is 
suggested (Helgeson, Escobar et al., 2010).  
 Frequent monitoring allows for early intervention and preventative techniques, such as 
coping skills training (Hood, Rausch & Dolan, 2011). Family-based interventions are also 
helpful (Hilliard et al., 2013; Wu et al., 2013) with particular regard to improving BGM 
(Hood, Rausch & Dolan, 2011). These interventions involve promoting the involvement of 
caregivers to share responsibility of self-management tasks in addition to reducing diabetes-
related family conflict (Ingerski et al., 2010).  
 Further longitudinal research on the relationship between depressive symptoms and 
metabolic control is warranted with consideration of the impact of variables that have been 
found to influence this relationship (e.g. peer and family relationships, BGM, disturbed eating 
behaviour). Research focuses on how depressive symptoms lead to poor metabolic control, 
suggesting a need for more studies investigating how metabolic control can exacerbate 
depressive symptoms (Stewart, Rao & White, 2005). It would be helpful for future work to 




conducting more frequent follow-ups, allowing for the identification of changes and 
fluctuations that might otherwise go undetected.  
 Conclusions.  There are inconsistencies in the literature regarding the long-term 
relationship between depressive symptoms and metabolic control in adolescents with T1D. 
What is clear is that this relationship is not independent from the influence of other factors. 
Although there is growing research investigating issues regarding metabolic control and 
depressive symptoms in adolescents with T1D, few studies report the nature of this 
relationship longitudinally, with fewer actively monitoring this interaction at multiple points 
over time. Confirmation of associations between depressive symptoms and metabolic control, 
alongside the absence of rigorous scientific research exploring directionality, cannot be stated 
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THE ROLE OF NEGATIVE AUTOMATIC THOUGHTS AND SELF-EFFICACY IN 





Background. Beck’s cognitive theory of depression (1967) posits that negative automatic 
thoughts (NATs) guide responses to specific stimuli and lead to depression. Bandura’s social 
cognitive theory (1997) proposes that depression stems from the beliefs an individual holds 
regarding their competence to achieve a particular goal (self-efficacy). Adolescents with Type 
1 diabetes (T1D) are particularly vulnerable to developing depression. 
 
Aims. This study explored the involvement of NATs and self-efficacy in depressive 
symptoms in adolescents with T1D. The influence of general and diabetes specific stress was 
considered, as was general and diabetes specific self-efficacy.  
 
Method. A cross-sectional questionnaire based study was conducted. Participants were 54 
adolescents with T1D aged between 13 and 18 years old.  
 
Results.  Higher levels of stress were associated with depressive symptoms and NATs. 
General stress was associated with general self-efficacy whereas diabetes specific stress was 
associated with diabetes specific self-efficacy. General self-efficacy and NATs were 
associated with depressive symptoms. However, NATs, general and diabetes specific self-
efficacy did not mediate the relationship between stress and depressive symptoms. 
 
Conclusions. The findings did not support the mediatory role of the cognitive constructs 
proposed by Beck and Bandura. Further research exploring the cognitive mechanisms that 






Type 1 diabetes. Type 1 diabetes (T1D) is an autoimmune disorder where the insulin 
producing beta cells in the pancreas are destroyed, creating a permanent deficiency of insulin 
(American Diabetes Association, 2013). The trend in prevalence rates suggests that the 
number of adolescents diagnosed with this chronic disease is rising yearly across Europe by 
an average of 3 – 4% (Patterson et al., 2012) with approximately 26 500 children and young 
people with this diagnosis in the UK alone (Diabetes UK, 2012). The management of T1D 
requires a complex treatment plan involving self-care tasks such as monitoring blood glucose 
levels, regulating and adjusting insulin via a specified mode of treatment (i.e. injections or 
insulin pump), and making important dietary adaptations and lifestyle changes to enhance 
general health (Silverstein et al., 2005). The adolescent period is a complex developmental 
stage in which many changes occur (e.g. hormonal, physical) in addition to other challenges 
experienced by adolescents such as concerns regarding acceptance within the peer group, 
developing an identity, and a growing desire for autonomy and independence (Cameron, 
2006). It is perhaps for these reasons that the demanding self-management regimen of T1D is 
less of a priority for some adolescents and why a decline in diabetes related outcomes is often 
observed during this time (Bryden et al., 2001). 
Depression. Depression is a mood disorder characterised by a cluster of behavioural, 
cognitive and somatic features including loss of interest in activities, thoughts of 
worthlessness and hopelessness, disturbances to regular patterns of sleep, changes in appetite 
and activity, and more overtly, low mood (American Psychiatric Association, 2013). The 
number of children and adolescents with a diagnosis of depression in the UK is estimated to 
be approximately 80 000 (Green, 2005). The extent to which depression affects this 




Verhulst, Penninx, & Ormel, 2014), increased risk of self-harm (Claes, Luyckx, & Bijttebier, 
2014) and consequently suicide (Brent et al., 1993).  
Type 1 diabetes and depression. Adolescents with T1D are at increased vulnerability 
to developing depressive symptoms (Johnson, Eiser, Young, Brierley, & Heller, 2013) and 
have demonstrated higher rates of depression compared to the general adolescent population 
(Hood et al., 2006; Kanner, Hamrin, & Grey, 2003; Whittemore et al., 2002). The co-
existence of depression in adolescents who have T1D has been reported to have negative 
connotations for the management of the illness (Hood et al., 2006), a possible consequence of 
the behavioural features such as a reduction in motivation interfering with the ability to 
perform self-care tasks (Lin et al., 2004). Depression can also hinder the initial process of 
adapting to the diagnosis (Lernmark, Persson, Fisher, & Rydelius, 1999) also leading to a 
reduction in diabetes self-care activities (Kovacs, Goldston, Obrosky, & Iyengar, 1992). Poor 
self-care creates further diabetes specific complications such as increased risk of developing 
retinopathy (Kovacs, Mukerji, Drash, & Iyengar, 1995) and, ultimately, hospitalisation 
(Stewart, Rao, Emslie, Klein, & White, 2005). The severity of the complications associated 
with depression in this population is evident particularly as adolescents with T1D are at 
increased risk of suicide (Goldston, Kovacs, Ho, Parrone, & Stiffler, 1994).  
A number of hypotheses have been proposed offering explanations for the 
development of depression in T1D. One possible reason is related to the highly demanding 
nature of the treatment and maintenance of self-management leading to difficulties in meeting 
treatment targets. This can create low mood which further prevents the meeting of treatment 
demands through the reduced motivation associated with depression (Lustman & Clouse, 
2005). Other hypotheses include the stress of having a chronic illness and the negative 




affecting resilience and the ability to cope (Nouwen, Urquhart Law, Hussain, McGovern, & 
Napier, 2009; Talbot & Nouwen, 2000).  
The recommended psychological treatment for depression in young people is 
cognitive behavioural therapy (Department of Health, 2005), which places focus on altering 
the dysfunctional cognitions characteristic of depression in order to change the associated 
negative affect (Beck, 1963). The emphasis on the role of cognitions in the treatment for 
depression suggests the need for consideration of cognitive theories and the underlying 
psychological mechanisms of depression in order to facilitate an understanding of its 
development in adolescents with T1D. Two leading cognitive theories of depression are 
Beck’s cognitive theory (1967) and Bandura’s social cognitive theory (1997).  
Beck’s cognitive theory of depression. Beck’s (1967) cognitive theory of depression 
posits that depression is the result of negative automatic thoughts representing underlying 
dysfunctional core beliefs developed in childhood. Core beliefs are defined as cognitive 
patterns that guide responses to a specific set of stimuli. In an individual with depression, the 
core beliefs include negative beliefs (cognitive distortions) that form the cognitive triad of 
depression (Beck, 1976) and skew the way they think about themselves, the world and the 
future. The relationship between core beliefs and behaviour is mediated by conditional 
statements often in the form of ‘if…then…’ statements labelled as dysfunctional assumptions 
that are developed from negative core beliefs (Greenberger & Padesky, 1995). When 
presented with a stressful event, the negative core beliefs are triggered and, through 
dysfunctional assumptions, lead to the production of negative automatic thoughts. These 
cognitions are rapidly available within the conscious mind and offer a negatively tinged 
evaluation of events (Westbrook, Kennerley & Kirk, 2007). Negative automatic thoughts that 




the development of depressive symptoms. Figure 1 illustrates the causal pathway to 




Figure 1. The pathway to depression as proposed by Beck’s cognitive model of depression. 
  
The validity of the mediating cognitive constructs in Beck’s model has been 
investigated with regard to the development of depression in adolescents. Moilanen (1995) 
found that higher levels of depressive symptoms were associated with a greater degree of 
dysfunctional assumptions, increased frequency of negative automatic thoughts and negative 
core beliefs. A stronger endorsement of dysfunctional assumptions was also related to greater 
levels of depressive symptoms in a study where core beliefs and negative automatic thoughts 
were not examined (Abela & Sullivan, 2003). 
 In terms of the validity of Beck’s model within the diabetic population, Clarke and 
Goosen (2009) investigated the role of regulating emotional stress in the development of 
depression in adults with diabetes. The findings showed that emotion focussed coping (i.e. 
strategies that attempt to regulate emotional stress) played a mediating role in the relationship 
between negative automatic thoughts and depression. Consistent with the cognitive model, the 
frequency of negative automatic thoughts was positively correlated with depressive 
symptoms. However the sample was not exclusive to those with T1D, but also included 
people with Type 2 diabetes. Furthermore, the age range of the sample (28 – 88 years) 
suggested a wide representation of the population of adults with diabetes but added little to 
clarify mechanisms in adolescents with T1D. Farrell and colleagues (2004) also reported that 










automatic thoughts, were associated with increases in the level of diabetes specific and 
general stress reported  by adolescents. General stress was thought to influence self-
management behaviour whereas diabetes specific stress was found to affect metabolic control 
directly, although the exact mechanisms of this relationship were not clear (Farrell, Hains, 
Davies, Smith, & Parton, 2004). The results suggest support for the role of the cognitions 
proposed by Beck in depression in T1D, however behavioural changes were measured (e.g. 
self-management) as opposed to depressive symptoms in response to distorted cognitions.  
Bandura’s social cognitive theory. Self-efficacy is a major component of Bandura’s 
(1997) social cognitive theory. Self-efficacy refers to the beliefs an individual holds regarding 
their competence to achieve given courses of action. According to this theory, depression 
results from the belief that one is inefficacious to gain valued outcomes. Figure 2 illustrates 
the pathway to depression as suggested by Bandura. 
 
  
Figure 2. The pathway to depression as proposed by Bandura’s social cognitive theory.   
 
Bandura’s theory has been tested in the general adolescent population. Consistent with 
the model, lower self-efficacy has been reported to be significantly associated with greater 
depressive symptoms (Muris, 2002). Similarly, Ehrenberg and colleagues (1991) found that 
self-reported levels of depression were negatively correlated with perceived general self-
efficacy in adolescents as well as academic and physical self-efficacy. In terms of the ways in 
which self-efficacy influences depression in adolescents longitudinally, the results of a path 
analysis showed that lower self-efficacy (social and academic) was associated with higher 








 In adolescents with T1D, lower self-efficacy and greater symptoms of depression were 
present in those who reported that diabetes had a greater impact on their quality of life (Grey, 
Boland, Yu, Sullivan-Bolyai, & Tamborlane, 1998). Stewart and colleagues (2000) explored 
self-efficacy as a mediator between emotional distress and metabolic control in adolescents 
with T1D in a cross-sectional, matched participants controlled study. Emotional distress was 
found to be significantly correlated with lower self-efficacy, which was associated with 
diabetes self-care. A follow-up study (Stewart, Wang, Wang & White, 2009) replicated these 
results demonstrating the relationship between emotional distress and self-efficacy, which was 
associated with self-care measured through metabolic control. However, metabolic control 
was the primary outcome measure as opposed to depressive symptoms and the age range of 
the sample used was relatively broad (9 to 21 years of age), covering varied developmental 
stages not exclusive to the adolescent period.  
Limitations of previous research. The evidence base exploring the role of cognitions 
readily available in conscious awareness (i.e. negative automatic thoughts and beliefs of self-
efficacy) in the development of depressive symptoms in adolescents with T1D is limited. 
Previous research did not encompass all the factors that are of interest in the current study. 
For example, although there is support for the model suggested by Beck and the role of 
negative automatic thoughts in depression in adolescents (Moilanen, 1995), this work has not 
been fully extended to adolescents with T1D. The mediating role of emotion-focused coping 
in the relationship between negative automatic thoughts and depression has also been 
demonstrated (Clarke & Goosen, 2009), but only within an adult sample. Self-efficacy has 
been found to be associated with metabolic control in adolescents with T1D (Grossman, Brink 
& Hauser, 1987), but little is known about its relationship to depression within this 




(Ehrenberg, Cox & Koopman, 1991), however no distinction has been made between general 
self-efficacy and self-efficacy specifically related to diabetes. Despite some of the papers 
incorporating measures of emotional adjustment, depressive symptoms were not always 
evaluated as the primary outcome measure. This is somewhat contrary to what is suggested by 
the respective models proposed by Beck and Bandura which recognise depression as a 
consequence of the mediating cognitive constructs. The previous literature also fails to 
differentiate between whether the depressive symptoms were the result of general stress or the 
stress experienced as a result of having T1D.  
In summary, the extent to which specific cognitive processes involved in the 
respective pathways described by Beck’s and Bandura’s models of depression, namely 
negative automatic thoughts and self-efficacy, have not been fully explored in adolescents 
with T1D. Equally, little attention has been paid to whether depression is a response to 
general stress or diabetes specific stress within this population. Determining the role of 
cognitive factors in depressive symptoms in adolescents with T1D could potentially help 
identify adolescents who may be at risk of developing depression. This will have implications 
for possible screening procedures and facilitate prevention and treatment interventions.  
Aims. This study aimed to investigate the role of cognitions readily available in 
conscious awareness, with a focus on negative automatic thoughts and self-efficacy, in the 
development of depressive symptoms within the same sample of adolescents with T1D. The 
aims of this study were therefore as follows:  
(i) To explore the cognitive mechanisms (negative automatic thoughts and self-
efficacy) that underlie depressive symptoms in the respective theories of 
depression to establish how much the mediating constructs of each theory are 




(ii) To investigate whether it is general self-efficacy or diabetes specific self-efficacy 
that is more strongly associated with depressive symptoms in this sample;  
(iii) To establish the extent to which general stress and diabetes specific stress 
influence depressive symptoms with regard to the cognitive mechanisms described 
by Beck and Bandura. 
 
Methodology 
Design. The research was a cross-sectional questionnaire based study. This design 
permitted the investigation of numerous variables at one time point and, as no research has 
been done in the area of interest, the design allowed for the initial discovery and identification 
of associations that can then be studied further. 
Measures. The self-report measures consisted of a questionnaire for 
sociodemographic data in addition to six questionnaires relating to the aims of the research. 
Sociodemographic information. Demographic and biographic data included age, 
gender, additional medical problems, history of depression, duration of T1D and treatment of 
diabetes (See Appendix 1). 
 Depressive symptoms. The primary outcome measure was depressive symptoms 
assessed using the Patient Health Questionnaire-9 (PHQ9; Spitzer et al., 1999; See Appendix 
2). This is a 9-item scale that assesses depressive symptoms over the past two weeks. 
Respondents used a 4-point Likert scale ranging from 0 ("Not at all") to 3 ("Nearly 
everyday") to rate symptoms of depression with higher scores indicating higher depressive 
symptoms. The measure has been found to be suitable for adolescents (Johnson, Harris, 





General stress. The Adolescent Stress Questionnaire (ASQ; Byrne, Davenport, & 
Mazanov, 2007; See Appendix 3) was used to assess general stress. The scale lists 58 stressful 
events and respondents were required to rate how stressful they found events experienced in 
the past year. Ratings were made using a 5-point Likert scale (1 = Not at all stressful/is 
irrelevant to me; 5 = Very stressful) with higher scores indicative of higher levels of stress. In 
addition to producing a total score, there are 10-subscales that assess stress in the following 
domains:  Home Life, School Performance, School Attendance, Romantic Relationships, Peer 
Pressure, Teacher Interaction, Future Uncertainty, School/Leisure Conflict, Financial 
Pressure, and Emerging Adult Responsibility. Cronbach’s alpha for the total score within the 
current sample was 0.96 and ranged from 0.71 to 0.89 for the subscales. 
Diabetes specific stress. Stress specifically associated with diabetes was assessed 
using the Problem Areas in Diabetes scale for teenagers (PAID-T; Polonsky et al., 2005; See 
Appendix 4). Respondents used a 5-point Likert scale to rate 20 items assessing diabetes 
specific emotional distress (0 = Not a problem; 4 = Serious problem). Higher scores indicated 
higher emotional distress specific to diabetes. Cronbach’s alpha for the current sample was 
0.94. 
Negative automatic thoughts. In line with Beck’s cognitive theory of depression, 
negative automatic thoughts were assessed using the Automatic Thoughts Questionnaire 
(ATQ; Hollon & Kendall, 1980; See Appendix 5). A 5-point Likert scale (1= Not at all; 5 = 
All the time) was used to rate how frequently respondents experienced 30 different negative 
automatic thoughts. A higher total score suggests a higher level of negative automatic 
thoughts. There were also four subscales that assess negative automatic thoughts related to: 




expectations, low self-esteem, and helplessness. Cronbach’s alpha for the total score was 0.93 
for the current sample and ranged from 0.41 to 0.82 for the subscale scores. 
General self-efficacy. With regard to Bandura’s theory, the Self-Efficacy 
Questionnaire for Children (SEQ-C; Muris, 2001; See Appendix 6) was used to assess general 
self-efficacy. This 24 item scale focuses on self-efficacy across three domains, namely social, 
academic and emotional. Respondents were required to rate how well they feel they do in 
each situation using a 5-point Likert scale (1 = Not at all; 5 = Very well); higher scores 
indicated greater self-efficacy. A total score is produced alongside three subscale scores. 
Cronbach’s alpha for the total score in the current sample was 0.90 and ranged between 0.81 
and 0.85 for the subscale scores. 
Diabetes specific self-efficacy. Self-efficacy related to diabetes was assessed using the 
Self-Efficacy for Diabetes Management Scale (SEDM; Iannotti et al., 2006; See Appendix 7). 
The SEDM consists of 10 items related to diabetes care. Respondents were required to rate 
how sure they are that they can do each of the diabetes care related activities using a 10-point 
Likert scale (1= Not at all sure; 10 = Completely sure). Higher scores indicated stronger self-
efficacy related to diabetes specific tasks. Cronbach’s alpha for the current sample was 0.86. 
Procedure. Ethical approval was obtained from the East Midlands Leicester Health 
Research Authority National Research Ethics Service (study reference: 13/EM/0066; See 
Appendix 8). Recruitment took place over eight months from August 2013 to March 2014. 
Young people who were deemed eligible based on the inclusion criteria were identified 
through diabetes clinics by their Paediatrician at routine medical appointments. Those who 
met the inclusion criteria were then provided with an invitation to participate (Appendix 9) 
and a Participant Information Sheet (Appendix 10) during their appointment. The invitation 




the current appointment or following their next appointment if they wished to take part, in 
addition to an option to decline to participate. If they wished to take part they met with a 
member of the research team following their routine appointment to complete the consent 
procedure. Eligibility was confirmed against exclusion criteria of: (1) having a diagnosis of a 
psychiatric condition, with the exception of major depression and dysthymia; (2) presence of 
a symptomatic co-morbid disease requiring treatment or self-management (e.g. asthma, 
cancer); (3) having a documented neurocognitive disorder; (4) less than 12-months post 
diagnosis
3
; and (5) not fluent English speakers. For those who remained eligible and were 
happy to continue, a consent form was signed (Appendix 11). Participants were requested to 
complete the questionnaires described above at the diabetes clinic. Participants were given the 
opportunity to have parents or carers present during the completion of the questionnaires. 
Following the completion of questionnaires, the HbA1c value from the clinic appointment 
was recorded. HbA1c is a measure of metabolic control and is the proportion of glucose 
molecules attached to haemoglobin in the blood and represents an average level of blood 
glucose over an eight to twelve week period (Rewers et al., 2009).  
Participants.  Participants were adolescents with a diagnosis of T1D aged between 13 
and 18 years who were recruited from five diabetes clinics in the West-Midlands where they 
were receiving care from a multi-disciplinary team. A total of 99 young people were 
approached to take part, 21 of whom declined to participate and five left the clinic before 
discussing the research. Ten young people requested to meet at their next appointment at the 
clinic, however, due to logistical reasons, this was not possible. Of the remaining young 
people who consented to participate (n = 63), one withdrew from the study before completing 
the questionnaires, four failed to fully complete the questionnaires and four were excluded as 
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 Depressive symptoms are more prevalent following initial diagnosis. They can resolve between 6 – 12 months 




they were approached in error and were either too young, had Type 2 diabetes or had 
cognitive difficulties that lead to difficulty when completing the questionnaires. Data were 
therefore collected from a sample of n=54 young people. The social, demographic and 




 N = 54 
Gender (N, %)  
Male  28 (51.9) 
Mean Age in years (SD) 15.39 (1.73) 
Ethnicity (N, %)  
White 24 (44.4) 
Asian  18 (33.4) 
Black  6 (11.1) 
Chinese 1 (1.9) 
Mixed background 4 (7.4) 
Other 1 (1.9) 
Employment/Education status (N, %)  
In education 49 (90.7) 
Full time employment 0 (0) 
Part time employment 1 (1.9) 
Not employed 4 (7.4) 
Mean diabetes duration in years (SD) 6.78 (4.11) 
Diabetes control (N, %)  
Tablets 2 (3.7) 
Insulin injections 41 (75.9) 
Insulin pump 11 (20.4) 
Mean HbA1c in % (SD)* 10.2 (2.0) 
Co-morbid health problems  
Number with additional health problems 12 (22.2) 
Depression status (based on self-report)  
No current/previous diagnosis 49 (90.7) 
Current/previous diagnosis 5 (9.3) 
Currently taking medication for depression 0 
*HbA1c values above 14 were not detected by the apparatus used to calculate HbA1c. N=4 had values of >14 
therefore this figure is not entirely representative. 
  
 Statistical analysis. Sociodemographic information and the scores from the 
questionnaires were described using descriptive data. The dependent variable in the statistical 




data and the parametric inference assumptions for all of the variables were undertaken using 
the Kolmorgorov-Smirnov Z test. The results reported that all data were normally distributed 
apart from the ATQ total score. A logarithmic transformation was used to transform this 
variable and corrected the deviation in ATQ total scores, which was then found to be 
normally distributed. Parametric tests were used to analyse the data. Bivariate statistics 
(Pearsons correlation) were used to explore correlations between all of the variables. 
 The two theories investigated in this study suggest that cognitions are mediators in the 
development of depression. Therefore the most appropriate statistical analysis to explore the 
relationship between stressors and depressive symptoms as mediated by cognitions was a 
mediation analysis as described by Preacher and Hayes (2008). This method allowed for the 
examination of a range of pathways including the direct effect of stress on the mediating 
variables (i.e. negative automatic thoughts and self-efficacy) and on depressive symptoms, 
and the effect of the mediating variables on depressive symptoms.  
The mediational approach was used to test two models: a general stress model and a 
diabetes specific stress model. For the general stress model, the analysis examined whether 
negative automatic thoughts, general self-efficacy and diabetes specific self-efficacy mediated 
the relationship between general stress and depressive symptoms. For the diabetes specific 
stress model, the analysis examined whether negative automatic thoughts, general self-
efficacy and diabetes specific self-efficacy mediated the relationship between diabetes 
specific stress and depressive symptoms. The variables included in the mediation analysis 
were transformed into standard scores (mean = 0, SD = 1) to facilitate direct comparison 
between parameter coefficients within the mediation models. A bias correcting bootstrapping 




mediating constructs on the relationship between stress (general and diabetes specific) and 
depressive symptoms. 
 The proposed mediation model for general stress is presented in Figure 3. According 
to the model proposed by Beck (1967) the relationship between general stress and depressive 
symptoms is mediated by negative automatic thoughts. In contrast, the model proposed by 
Bandura (1997) depicts the relationship between general stress and depressive symptoms as 
mediated by beliefs of self-efficacy, both general self-efficacy and self-efficacy specific to 
diabetes. Accordingly, the predictions of Beck and Bandura may be directly compared in the 
mediation model presented in Figure 3. The parameter estimation and the mediation analysis 
were conducted according to the procedure described by Preacher and Hayes (2004, 2008).  
 
Figure 3: The proposed model of the mediating effects of self-efficacy beliefs and negative 














A second mediation analysis was undertaken to explore the mediating effects of self-
efficacy beliefs and negative automatic thoughts upon the relationship between diabetes 
specific stress and depressive symptoms. The proposed mediation model is presented in 
Figure 4.  
 
Figure 4: The proposed model of the mediating effects of self-efficacy beliefs and negative 
automatic thoughts on the relationship between diabetes specific stress and depressive 
symptoms. 
 
 To establish mediation effects, the relationship between stress and depressive 
symptoms must be significant. There must also be associations between stress and the 
mediating variables in addition to associations between the mediating variables and 
depressive symptoms. Mediation effects can only be established if the association between 
stress and depressive symptoms diminishes after inclusion of the mediating variables. The 













regressions. The tests of significance of the mediated pathways were calculated using the 
bootstrap method (MacKinnon & Fairchild, 2009; Preacher & Hayes, 2004, 2008), and the 
Beta coefficient and associated bias corrected confidence intervals were calculated. The bias 
correcting bootstrapping technique tested for mediation by using 5000 bootstrapped samples. 
The mediation tests were reported as ‘indirect effects’ and represented the combined influence 
of general and diabetes specific stress upon the mediator(s) and the mediator(s) upon 
depressive symptoms. Mediation tests are considered statistically significant through 95% 
confidence intervals at α=0.05 if the confidence interval does not include zero.  
Power calculation. To determine an appropriate sample size based on the planned 
statistical analysis of a bias-corrected bootstrap mediation analysis, the guidance by Fritz and 
MacKinnon (2007) was used which outlines the number of participants required for different 
effect sizes. The current research was interested in robust phenomena that can be utilised 
clinically therefore medium effect sizes and above were selected. Accordingly, in order to 
detect a medium effect size to achieve a power of 0.80, a sample of size of n=71 was 
proposed for this study.  
Results 
Questionnaire scores. The descriptive statistics of the scores for the measures used to 
assess depressive symptoms (dependent variable), general and diabetes specific stress 
(independent variables), and the mediating variables of negative automatic thoughts, general 
self-efficacy and diabetes specific self-efficacy are presented in Table 2. The scores suggest 
that the current sample reported mild levels of depressive symptoms. The amount of general 
and diabetes specific stress experienced also appeared to be relatively low. However the 
maximum score on the ASQ is 290 compared to 100 on the PAID-T suggesting that this 




stress. Low self-efficacy, general and diabetes specific, was not reported by the sample as a 
whole. It is important to note that the standard deviations for all of the respective scores 
suggested a relatively large degree of variability within the data.     
 
Table 2  
Means (SD) on study questionnaire variables. 
 Mean SD 
Depressive symptoms (PHQ-9)
 4
 5.41 4.62 
General Stress (ASQ) 88.30 31.20 
Diabetes specific stress (PAID-T) 64.52 26.08 
Negative automatic thoughts (ATQ) 44.26 15.26 
General self-efficacy (SEQ-C) 82.61 15.98 
Diabetes specific self-efficacy (SEDM) 61.37 17.02 
 
 Stress and depressive symptoms. With regard to the relationship between general 
stress and depressive symptoms, the Pearson’s correlation test showed a significant positive 
correlation (r=0.70, p≤0.01). There was also a significant positive correlation between 
diabetes specific stress and depressive symptoms (r=0.72, p≤0.01). These results suggest that 
an increase in general and diabetes specific stress was associated with an increase in 
depressive symptoms. Both diabetes specific stress and general stress appeared to demonstrate 
a strong association with depressive symptoms.  
 Beck’s cognitive theory of depression. A significant positive correlation was found 
between the Beck’s negative automatic thoughts and general stress (r=0.54, p≤0.01) and also 
diabetes specific stress (r=0.56, p≤0.01), both demonstrating moderate associations. In terms 
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 Cut-off scores corresponding to depression severity on the PHQ-9 (Kroenke & Spitzer, 2002) are as follows: 0 




of the relationship between negative automatic thoughts and depressive symptoms, the scores 
from the measures were significantly positively correlated (r=0.48, p≤0.01), indicating that 
higher depressive symptoms are associated with higher levels of negative automatic thoughts.   
 Bandura’s social cognitive theory. The relationships between general stress and 
mediating variables revealed a significant negative correlation for general self-efficacy (r=-
0.38, p≤0.01), a relatively moderate association, but no significant association with diabetes 
specific self-efficacy. Conversely, diabetes specific stress was negatively correlated with 
diabetes specific self-efficacy (r=-0.33, p≤0.05), but not with general self-efficacy. Again the 
strength of the association was moderate. A weak but significant negative correlation was 
found between general self-efficacy and depressive symptoms (r=-0.28, p≤0.05). No 
significant result was found between depressive symptoms and self-efficacy related to 
diabetes.   
 Mediation analysis: General stress model. The association between general stress 
and depressive symptoms before the mediating effects of general and diabetes specific self-
efficacy and negative automatic thoughts were considered was significant (Beta = 0.539, 
95%CI 0.305 to 0.773). With the inclusion of the three mediating variables the direct link 
between general stress and depressive symptoms increased to Beta = 1.679 (95%CI 0.524 to 
2.835). Negative automatic thoughts was the only variable that was identified as a potential 
mediator in this analysis as it demonstrated a significant association with stress and 
depressive symptoms, respectively. However, the direct effect remained significant and none 
of the mediated paths were statistically significant (Beta = -1.140, 95%CI -2.780 to 0.312).  
Therefore, neither self-efficacy (general and diabetes specific) nor negative automatic 
thoughts mediated the relationship between general stress and symptoms of depression (Table 





Summary of mediation results for self-efficacy and negative automatic thoughts on the 























Beta = -0.293 
(-0.559 to -
0.027) 
Beta = -0.069 
(-0.320 to 
0.181) 






Beta = -0.120 
(-0.396 to 
0.156) 
Beta = -0.138 
(-0.380 to 
0.103) 







Beta = 0.979 
(0.924 to 
1.035) 
Beta = -1.201 
(-2.350 to –
0.052) 
Beta = -1.177 
(-2.88 to 0.23) 
Beta = 1.679 
(0.524 to 
2.835) 
Beta = 0.539 
(0.305 to 
0.773) 




Figure 5. Model demonstrating the mediation results for self-efficacy and negative automatic 
























Mediation analysis: Diabetes specific stress model. As with the general model, a 
significant total effect (Beta = 0.717, 95%CI 0.522 to 0.911) between diabetes specific stress 
and symptoms of depression was observed before the inclusion of mediating effects of self-
efficacy and negative automatic thoughts. When these variables were considered, the direct 
effect between diabetes specific stress and depressive symptoms were Beta = 0.958 (95%CI 
0.409 to 0.9069). Again the direct effect remained significant but none of the mediated paths 
were statistically significant (Beta = 0.059, 95%CI -0.095 to 0.217) indicating that self-
efficacy and negative automatic thoughts did not mediate the relationship between diabetes 
specific stress and symptoms of depression (Table 4). 
 
Table 4  
Summary of mediation results for self-efficacy and negative automatic thoughts on the 

























Beta = -0.262  
 (-0.531 to 
0.007)    
Beta = -0.103  
(-0.316 to 
0.111) 






Beta = -0.330  
(-0.593 to -
0.067) 
Beta = 0.067 
 (-0.1492  to 
0.2826) 







Beta = 0.559   
(0.328 to 
0.789) 
Beta = 0.096 
 (-0.145 to 
0.337) 
Beta = 0.054 
(-0.100 to 
0.208) 
Beta = 0.658 
(0.409 to 
0.907) 
Beta = 0.717 
(0.522 to 
0.911) 








Figure 6. Model demonstrating the mediation results for self-efficacy and negative automatic 
thoughts on the relationship between diabetes specific stress and depressive symptoms. 
 
Discussion 
 This study set out to investigate the role of cognitions in depressive symptoms in 
adolescents with T1D. The mediating constructs of negative automatic thoughts (as proposed 
by Beck’s cognitive theory of depression) and the notion self-efficacy (as per Bandura’s 
social cognitive theory) were explored within the same sample of adolescents with T1D to 
determine the degree of their involvement in depressive symptoms. The role of general self-
efficacy and diabetes specific self-efficacy were also tested to identify the extent to which 
each type is associated with depressive symptoms, similarly general stress and stress 
























The findings demonstrated that both general stress and diabetes-specific stress, 
independent of the cognitive mediators, were associated directly with depressive symptoms 
suggesting that higher levels of stress are related to higher reported depressive symptoms. 
This association remained significant after the inclusion of negative automatic thoughts and 
self-efficacy (both general and diabetes specific), suggesting that these cognitions did not 
mediate the relationship between stress and depressive symptoms in this sample. However, 
associations were identified when examining the individual relationships between stress, 
mediators and symptoms of depression. 
Higher levels of general and diabetes specific stress were associated with more 
frequent negative automatic thoughts, consistent with previous findings within this population 
(Farrell et al., 2004). This is consistent with the theory proposed by Beck whereby depression 
results from negative automatic thoughts fuelled by underlying beliefs that guide responses to 
a specific set of stimuli, in this case, general stress. However, these cognitions only appeared 
to be associated with depressive symptoms in the mediation model of general stress. Thus 
supporting previous results from a non-diabetic sample (Moilanen, 1995) but in contrast to 
research examining the role of negative automatic thoughts in those with T1D (Clarke & 
Goosen, 2009). It should be noted that the study by Clarke and Goosen did suggest that there 
was an extra dimension to the process in the form of emotion focussed coping that mediated 
the relationship between negative automatic thoughts and depression, a factor that was not 
explored in the current study. The discrepancies between findings may be a consequence of 
previous research employing different methodologies and different outcome measures. 
Despite a positive correlation with depressive symptoms, the lack of association in the 
mediation model of diabetes specific stress suggested that experiencing stress solely 




automatic thoughts. A possible reason for this may be that the diabetes specific stressors were 
not strong enough to activate the engrained, underlying core beliefs. Similarly, as the average 
level of depressive symptoms within the sample was relatively mild, the mediating pathway 
was perhaps inactive as there were no depressive symptoms in response to stress to mediate.  
With regard to self-efficacy, an increase in general stress was only associated with 
lower beliefs of general self-efficacy, whereas diabetes specific stress was associated with 
lower self-efficacy related to diabetes specific tasks. This suggests that general stress may 
have an effect on a broader set of beliefs whereas stress associated with T1D can have a 
negative impact on the management of the illness as a result of poor self-efficacy and beliefs 
in the ability to carry out self-care tasks. However the results were not as expected based on 
Bandura’s (1997) social cognitive theory whereby depression results from low self-efficacy as 
neither type of self-efficacy was associated with depressive symptoms in the mediation 
analysis. Furthermore, they were not in-line with the previous literature where lower self-
efficacy was associated with more symptoms of depression in the general adolescent 
population (Ehrenberg et al., 1991; Muris, 2002; Smith & Betz, 2002). This may be a result of 
difficulties with low self-efficacy not being present in this sample in addition to the mild 
levels of depressive symptoms.    
In summary, the findings were mainly inconsistent with the theories proposed by Beck 
and Bandura in that the only cognitions associated with depressive symptoms in the mediation 
analysis were negative automatic thoughts but only when the stressor was general stress. Yet, 
as suggested by the theories proposed by Beck and Bandura, the presence of poor self-
efficacy and more frequent negative automatic thoughts are associated with depressive 
symptoms in this sample. In contrast to the findings of the mediation analysis, previous 




alongside significant associations between stress and the mediating variables. Therefore this 
population appears to be vulnerable to developing depressive symptoms due to the presence 
of the mediating variables that are associated with stress, a relationship that appears to be 
cyclical in nature.   
Limitations. The discrepancies between the conclusions drawn from the current study 
and previous work may be the result of a number of methodological limitations. Firstly, with 
regard to the measures that were used, although reliability and validity had been demonstrated 
for use within the adolescent population, the measures that were not specifically looking at 
diabetes-related factors (e.g. PHQ-9, ASQ, SEQ-C, ATQ) had not been standardised within 
the adolescent T1D population. This limitation can also be applied to the fact that the sample 
was relatively diverse in terms of ethnicity and the measures may not have been sensitive to 
different cultural backgrounds. Secondly, the questionnaires were all self-report measures that 
were completed at attendance at routine clinic appointments. An element of social desirability 
bias may have threatened internal validity, where difficulties may have been minimised and 
scores were not reflecting the difficulties experienced. Finally, the measure for depressive 
symptoms has been used widely as a screening tool and perhaps assessment of depressive 
symptoms through a more formal diagnostic interview would have provided a more 
comprehensive assessment of depression, allowing opportunity for exploration of individual 
areas of difficulties. Similarly, Bandura and colleagues (1999) found that different types of 
self-efficacy (social, academic, educational) were related to greater or fewer depressive 
symptoms. An in depth examination of these individual subscales as opposed to using total 
scores could have provided a clearer picture of the mechanisms associated with depressive 




 Further limitations were in relation to the sample. In comparison to other studies 
within this field, the sample size was relatively small and the number of those who 
participated was lower than anticipated. This not only reduced the power of the study but also 
increased the risk of a type 2 error i.e. failing to detect a difference where one is present. 
Furthermore, the characteristics of the sample in terms of the sociodemographic features 
suggest that the results cannot perhaps be generalised to other populations. Despite being 
relatively small, the diversity of the sample in terms of age also raises questions whether the 
developmental stages covered were too broad. For example, the views and life experiences of 
a 13-year old are likely to be incomparable to those of an 18-year old yet age was not 
explored in the current study as a covariate. Also, older participants may be required to be 
more autonomous in the management of their diabetes, which potentially could increase stress 
levels. Similarly the difference in diabetes duration could suggest that those with a longer 
time since diagnosis may be better equipped for dealing with the demands of the illness and 
perhaps less likely to experience elevated levels of stress related to diabetes. Inclusion of a 
control group of non-diabetic adolescents would have facilitated in establishing how much 
stress is related to diabetes and how much is general teen angst. Although measures were used 
to differentiate between the two types of stress, there was likely to be some crossover as 
having T1D may exacerbate the stress experienced in general situations.  
The lack of consideration of external factors could have impacted on the variables of 
interest that were explored in this study. For example, a history of depression has been found 
to increase the risk of stress impacting on self-efficacy, which in turn leads to greater 
vulnerability in developing future depressive symptoms (Maciejewski, Prigerson, & Mazure, 
2000). Data on previous depression was collected however was not included in the analysis in 




of depression. There is also evidence of a relationship between parental cognitive mechanisms 
and the cognitive mechanisms of young people. For example, depression in mothers with 
children who have T1D is associated with child depressive symptoms (Jaser, Whittemore, 
Ambrosino, Lindemann, & Grey, 2008). Low parental mood has also been found to have a 
negative effect on parental perceptions of adolescent self-efficacy, which is associated with 
the adolescent having a negative perception of their own self-efficacy (Butler et al., 2009). 
Again, these factors were not considered in the current research. 
Clinical implications. Implications for clinical practice can be inferred from the 
results, despite the mediation models not being statistically significant. Stress appears to have 
a negative association with the cognitions involved in the development of depressive 
symptoms. A screening tool incorporating measures of stress and low mood may be helpful in 
identifying those who may require intervention and perhaps prevention approaches. Issues 
may arise with self-report tools within this population (Esbitt, Tanenbaum & Gonzalez, 2012) 
therefore more practical approaches to monitor mood may be used within the clinical setting. 
For example, Fogel and Weissberg-Benchall ( 2010) suggest that asking questions such as 
“Have you been feeling more sad or down than usual?” and “Have you noticed that things that 
used to be fun are not so much fun anymore?” (p. 437) can be used as indicators of when 
further exploration and intervention may be required.  
 In terms of interventions for stress, techniques could be collaboratively established 
with healthcare practitioners to focus on strategies the young people already have in place to 
reduce stress (e.g. engaging in an activity, relaxation based strategies). Additional 
interventions may be based on psychoeducation on how to recognise stress (Hood, Rausch, & 
Dolan, 2011). This will then serve as an indicator of when to implement strategies to reduce 




psychoeducation to parents and carers to increase their awareness of signs that the young 
person is experiencing levels of stress and may require additional support or prompting to 
utilise coping techniques. 
 Self-efficacy has been found to be key in the self-management of diabetes in 
adolescents (Iannoti et al., 2006) and can also be reinforced by healthcare practitioners at 
routine appointments. It has been suggested that this is done through active involvement of 
the young person in their care (e.g. through addressing them during appointments), providing 
education, and helping them to tackle hindrances and barriers with non-judgemental problem 
solving (Stewart, Rao & White, 2005). In terms of more formal interventions for adolescents 
with T1D, research suggests that coping skills training with a focus on resolving problems 
that are encountered in terms of managing T1D is effective (Davidson, Boland & Grey, 1997). 
This approach has been found to improve self-efficacy and diabetes specific health outcomes 
(Grey, Boland, Davidson, Li, & Tamborlane, 2000; Whittemore, Jaser, Guo, & Grey, 2009). 
  With regard to negative automatic thoughts, cognitive behavioural interventions 
stemming from Beck’s model have been found to be effective in reducing depressive 
symptoms within individuals with diabetes (Balhara & Verma, 2013). This approach targets 
the negative automatic thoughts that are triggered by stress with a view to reduce an 
individual’s vulnerability to developing depressive symptoms.   
 As the results of the current study were mixed and inconsistent with previous work, 
further investigation of cognitions and their role in the development of depressive symptoms 
in adolescents with T1D is warranted. Exploration of the factors that influence these 
cognitions in adolescents with T1D, such as parental cognitions, were beyond the scope of the 




Conclusions. The current study has highlighted variables that potentially identify 
those who may be at risk of developing depressive symptoms. In terms of the mediating role 
of the cognitions investigated, neither automatic thoughts nor self-efficacy (general or 
diabetes specific) were found to be significant mediators in the relationship between stress 
and depressive symptoms. Yet associations were established between individual parts of the 
models. The main findings were that general stress leads to more negative automatic thoughts 
and lower self-efficacy, with the former creating an increase in depressive symptoms whereas 
diabetes specific leads to lower diabetes specific self-efficacy. Furthermore, both general and 
diabetes specific stress were strongly associated with depressive symptoms. The limitations 
discussed may explain why results were not entirely consistent with the theories of Beck and 
Bandura in terms of the mediating roles of the investigated cognitions. Despite the findings, 
adolescents who have T1D demonstrate significantly higher rates of depression compared to 
the general population (Kanner et al., 2003) and are a particularly vulnerable sample that 
require consistent monitoring and appropriate intervention. Effective screening procedures are 
required to identify and monitor young people at risk of developing depressive symptoms 
(Schwartz, Axelrad, Cline, & Anderson, 2011). Preventive measures may reduce the 
economic burden that T1D and depression place on the healthcare system (Egede & Ellis, 
2010). More importantly, awareness and promotion of the psychosocial wellbeing of this 
group provides healthcare practitioners and family members with the means to support young 
people and empower them through shared decision making and collaboration with those 
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This document provides a summary of the two research components that were 
submitted as part of a thesis in partial fulfillment for the qualification of Doctorate of Clinical 
Psychology (Clin.Psy.D.) at the University of Birmingham. The literature review and 
empirical paper explored depressive symptoms in adolescents with Type 1 diabetes (T1D). 
Adolescents with T1D are more vulnerable to developing depressive symptoms than their 
peers (Johnson, Eiser, Young, Brierley & Heller, 2013; Kanner, Hamrin, & Grey, 2003) and 
the presence of depressive symptoms can have a negative influence on the self-management 
of T1D (Hood et al., 2006). For example, a reduction in motivation (a symptom of 
depression) can interfere with self-care tasks (Kovacs, Goldston, Obrosky, & Iyengar, 1992; 
Lin et al., 2004) which can then lead to further diabetes-related complications. More 
specifically, higher levels of depressive symptoms in adolescents with T1D have been found 
to be associated with poorer metabolic control (e.g. Hood et al., 2006; Kovacs et al., 1995; La 
Greca & Bearman, 2002). It is therefore important to gain an understanding of the processes 
that underlie depressive symptoms in adolescents with T1D and also to examine the 
relationship between depressive symptoms and metabolic control. 
 
Literature review: The longitudinal relationship between depressive symptoms and 
metabolic control in adolescents with Type 1 diabetes 
 The literature review synthesised and evaluated research that was conducted over a 
period of time (longitudinal research) investigating the relationship between depressive 
symptoms and metabolic control. The aim of the review was to gain a clearer understanding 
of directionality within this relationship (i.e. Do depressive symptoms lead to poorer 
PUBLIC DOMAIN BRIEFING DOCUMENT 
86 
 
metabolic control or vice versa?). Additional factors that may influence this relationship were 
also explored.  
The fourteen studies that were identified from the evidence base revealed mixed 
findings, with most research exploring the influence of depressive symptoms on metabolic 
control. A number of studies suggested that depressive symptoms at baseline had a negative 
effect on subsequent values of metabolic control at follow-up but that this association 
decreased over time. However, it was important to note that this relationship was not 
independent of the influence of other factors, including: the frequency of blood glucose 
monitoring, the occurrence of stressful life events, family conflict, parental involvement in 
diabetes self-care, and peer relationships. Further research is needed in order to clarify the 
nature of the relationship between depressive symptoms and metabolic control over time in 
adolescents with T1D.  
 
Empirical paper: The role of negative automatic thoughts and self-efficacy in depressive 
symptoms in adolescents with Type 1 diabetes 
 Background. Two leading theories of depression suggest that particular styles of 
thinking lead to the development of depression. Beck’s cognitive theory of depression (1967) 
suggests that unhelpful thought patterns, called negative automatic thoughts, influence an 
individual’s interpretation of events and lead to depression. This theory has been tested such 
that an increase in the frequency of negative automatic thoughts has been found to be  
associated with higher levels of depressive symptoms in adolescents (Moilanen, 1995) and 
adults with diabetes (Clarke & Goosen, 2009). Bandura’s social cognitive theory of 
depression (1997), states that the beliefs an individual holds regarding their ability to achieve 
a particular goal (self-efficacy) are associated with the development of depression. Lower 
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self-efficacy has been reported to be associated with greater depressive symptoms in the 
general adolescent population (Ehrenberg et al., 1991; Muris, 2002; Smith & Wood, 2007) 
and in adolescents with T1D who reported that diabetes had a greater impact on their quality 
of life (Grey, Boland, Yu, Sullivan-Bolyai, & Tamborlane, 1998).  
 Aims. The research aimed to explore negative automatic thoughts and self-efficacy to 
establish how much they are involved in depressive symptoms in adolescents with T1D. 
Stress (both diabetes specific and general) was explored with regard to its influence on 
depressive symptoms. General self-efficacy and diabetes specific self-efficacy were also 
investigated to determine whether one is more strongly related to depressive symptoms than 
the other.  
 Method. A cross-sectional, questionnaire based design was used. Participants were 
recruited from five paediatric and young adult diabetes clinics in the West Midlands, and 
consisted of 54 adolescents with T1D aged between 13 and 18 years old.  
 Results. The results showed that increases in general and diabetes specific stress 
increased were associated with increases in negative automatic thoughts. In terms of self-
efficacy, as general stress increased general self-efficacy decreased, whereas increases in 
diabetes specific stress were associated with a reduction in diabetes specific self-efficacy. 
Higher depressive symptoms were associated with higher levels of negative automatic 
thoughts and lower beliefs of general self-efficacy but not with self-efficacy related to 
diabetes. Both general stress and diabetes specific stress were strongly associated with 
depressive symptoms. There was no evidence to suggest that negative automatic thoughts 
and/or self-efficacy mediated (explained) the relationship between stress and depressive 
symptoms, however negative automatic thoughts were associated with depressive symptoms 
but only when the stressor was general stress. 
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 Conclusions. The findings were mixed in terms of supporting the respective theories 
proposed by Beck and Bandura. There was evidence to support the role of negative automatic 
thoughts and self-efficacy in depressive symptoms in adolescents with T1D. Increases in both 
types of stress were associated with an increase in reported negative automatic thoughts. 
However, general stress was only associated with lower general self-efficacy and, similarly, 
diabetes specific stress was associated with a reduction in diabetes specific self-efficacy. 
Higher levels of stress (general and diabetes specific) were associated with higher levels of 
depressive symptoms. Therefore this population appears to be vulnerable to developing 
depressive symptoms due to the association with negative automatic thoughts and lower self-
efficacy triggered by stress. Further research exploring the thought patterns that underlie 
depressive symptoms in adolescents with T1D is required. 
 
Implications for clinical practice 
 The findings of the literature review and empirical paper highlight the vulnerability of 
adolescents with T1D. It is therefore recommended that they receive ongoing monitoring for 
emotional difficulties (Colton, Olmsted, Daneman, & Rodin, 2013). To ensure vulnerabilities 
are detected, the administration of parental reports of adolescent distress in addition to 
adolescent self-reports is recommended. This will help to identify difficulties not disclosed by 
the adolescent. Furthermore, the use of continuous scores as opposed to cut-off scores is 
recommended to ensure that underlying difficulties and mild symptoms of emotional distress 
are not overlooked (Hilliard, Herzer et al., 2011) and to enable more accurate monitoring. 
  Discussions regarding the impact of stress on T1D by healthcare professionals will be 
helpful (Helgeson, Escobar et al., 2010). Questions such as “Have you been feeling more sad 
or down than usual?” and “Have you noticed that things that used to be fun are not so much 
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fun anymore?” can be asked at clinic appointments to monitor mood and stress levels (Fogel 
& Weissberg-Benchell, 2010). Self-efficacy can also be reinforced at appointments through 
actively involving the young person in their care, providing education and helping them tackle 
hindrances and barriers with non-judgmental problems solving (Stewart, Rao & White, 2005). 
Parents and carers can also support adolescents in recognising signs of stress to act as cues of 
when to implement stress reduction strategies. 
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Data extraction 1 
Summary of findings from the literature regarding directionality in the relationship between depressive symptoms and metabolic control over 
time. 
* Studies presented in chronological order. 
** ‘Sample characteristics’ describes the whole sample at baseline unless otherwise specified. 
RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  




Study contact points  
 
Overall retention rate 







Mean age (years)[sd] 
Age range (years)  
 
Diabetes duration (DD; 
years) 
Measure of 










Relationship between depressive symptoms and 
HbA1c over time 
 
Overall conclusion  with regard to directionality 
Kovacs, Iyengar, 
Goldston, Stewart, 





3 – 4 times over next 
year  
Then every 8 – 12 m 
for up to 6 years 
(Average follow up 
time = 73 months ) 
RR = 89% 
N = 95 
Female/Male = 51/44 
 
Mean age = 11.1 [n.r.] 
Age range = 8.3 – 13.9 
 
DD = Newly diagnosed 
 













Depressive symptoms were not associated with levels 
of HbA1c over time.  
 
No conclusion can be drawn with regard to 







RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  
  
Study reference  Sample characteristics Measure of 










3 – 4 times over next 
year then every 8 – 12 
m for the study 
duration (Average 
follow up time = 8.6 
years ± 2.9 ) 
 
RR = 75% 
N = 88 
Female/Male = 46/42 
 
Mean age = 11.0 ± [1.5] 
Age range = 8.1 – 13.8 
 
DD = 6.3 ± [3.7] 
 









At each study contact 
 
 
After 12 months, 
every 4 – 6 months 
 
 
A diagnosis of depressive disorder alone was not 
significantly associated with HbA1c over time.  
 
No conclusion can be drawn with regard to 
directionality over time. 
 
Northam, Matthews, 
Anderson, Cameron & 






RR = n.r. 
N = 41 
Female/Male = 18/23 
 
Mean age = 14.9 ± [2.1] 
Age range = 11 – 18 
 
DD: Age at Diagnosis = 








for Children and 
Adolescents-IV 




Every three months 




No association was found between internalising 
behaviours on the CBCL (including depressed 
behaviour) at baseline and diagnosis of a psychiatric 
disorder or metabolic control at 10-year follow-up. 
 
No conclusion can be drawn with regard to 





RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  
  
Study reference  Sample characteristics Measure of 










12 months  
2 years   
3 years  
 
RR = 96% 
N = 132 (dyads) 
Female/Male = 70/62 
 
Mean age = 12.1 ± [0.77] 
Age range = 10.73 – 
14.21 
 
DD = 4.91 ± [2.98]  
 
Children’s Depression  
Inventory – 
Abbreviated form  
(Kovacs, 1985, 2001) 
 
Baseline 
12 months  
2 years   




12 months  
2 years   
3 years  
 
 
Increases in HbA1c over time were predicted by 
depressive symptoms from the previous point of 
assessment (B = 1.18, p < 0.01). The predictive value 
of CDI scores in determining the deterioration in 
HbA1c decreased over time. When depression was 
entered in to a model to determine whether its ability to 
predict change in HbA1c over time was independent of 
other predictors, results indicated that its predictive 
value was accounted for by the other predictor 
variables (i.e., bulimic symptoms, negative peer 
relationships). 
 
Greater depressive symptoms predict an increase in 
HbA1c over time.  
Helgeson, Escobar, 





12 months  
2 years   




N = 132 
Female/Male = 70/62 
 
Age = 12.10 [n.r.] 
Range = 10.73 – 14.21 
 
DD = 4.91 ± [2.96] 
 
 
Children’s Depression  
Inventory  
 – Abbreviated form 
(Kovacs, 1985, 2001) 
 
Baseline 
12 months  
2 years   





12 months  
2 years   




When predicted by stressful life events, depressive 
symptoms were associated with metabolic control 
using multi-level modelling statistical analysis (0.744, 
p < 0.05) but were not found to be a mediator in the 
relationship between life events and HbA1c. 
 
Greater depressive symptoms are associated with an 





RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  
  
Study reference  Sample characteristics Measure of 











12 months  
2 years   




N = 132 
 
Gender = Not reported 
 
Mean age = 12.1 [n.r.] 
Age range = 10.7 – 14.2 
 
DD =  Not reported 
 
 
Children’s Depression  
Inventory – 
Abbreviated form 






12 months  
2 years   




Two trajectories of HbA1c were revealed during the 
duration of the study: stable/good control and poor 
control that deteriorates over time. Depressive 
symptoms did not influence trajectory membership.  
 
No conclusion can be drawn with regard to 
directionality over time. 
 
Ingerski, Anderson, 




6 months  
 
RR = 98% 
N = 147 (dyads) 
Female = 52% 
 
Mean age = 15.5 ± [1.4] 
Age range = 13 – 18 
 
DD = 6.0 ± [3.8] 
 











Symptoms of depression reported by adolescents and 




No conclusion can be drawn with regard to 
directionality over time. 
 
McGrady & Hood 






RR = n.r. 
N = 144 (dyads) 
Male = 48% 
 
Mean age = 15.5 ± [1.4]  
Age range = 13 – 18 
 
DD = 5.9 ± [3.8]  











No significant association was found between 
depressive symptoms at baseline and HbA1c at 6 
months.  
 
No conclusion can be drawn with regard to 





RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  
  
Study reference  Sample characteristics Measure of 











RR = n.r. 
N = 90 (sub-sample of 
complete data set) 
Female = 51.1% 
 
Mean age = 15.8 ± [1.4] 
Age range = 13 – 18 
 
DD = 6.4 ± [3.7] 










When entered into a regression model with other 
variables that were significantly correlated with blood 
glucose monitoring frequencies (BGM), depressive 
symptoms at baseline predicted HbA1c and accounted 
for 4.76% of the variance in HbA1c levels at 3 months 
(B = 0.09, p < 0.05).   
 
Depressive symptoms make a relatively small 
contribution to an increase in HbA1c over time. 
Hilliard, Herzer, 






RR = 97% 
N = 145 (dyads) 
Female = 51.3% 
 
Mean age = 15.5 ± [1.4]  
Age range = 13 – 18 
 
DD = 6.0 ± [3.9] 











At baseline, higher CDI scores were correlated with 
higher HbA1c (r = 0.22, p <0.01), but were not 
significant in predicting HbA1c at 12 months.  
 
No conclusion can be drawn with regard to 
directionality over time. 
 







RR =  n.r. 
N = 145 
Female =  52.4% 
 
Mean age = 15.5 ± [1.4] 
Age range = 13 – 18 
 
DD = 5.9 ± [3.8] 












CDI scores decreased significantly from baseline to 
follow-up (B = 0.11, p < 0.001) as HbA1c levels 
increased. Changes in CDI scores did not demonstrate 
significant predictive value for overall change in 
HbA1c over time.  
 
No conclusion can be drawn with regard to 




RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  
 
  
Study reference  Sample characteristics Measure of 












RR : N = 98 at 
baseline & at 5 years 
 
N = 98 
M/F = 0/98 
 
Age = 11.7 ± [1.5] 
Range = 9 – 14 
 
DD = 4.8 ± [2.9] 
 


















Females who reported current or past depression did 
not have significantly worse metabolic control to those 
who did not. 
 
Baseline depressive symptoms did not predict HbA1c 
at 5 years.  
 
No conclusion can be drawn with regard to 
directionality over time. 
 
Hilliard, Wu, Rausch, 








RR = 89% 
N = 150 (dyads) 
Female = 51% 
 
Mean Age = 15.5 ± [1.4]  
Age Range = 13 – 18 
 
DD = 6 ± [3.9]  














Higher depressive symptoms at baseline predicted that 
adolescents would fall within the ‘normatively similar’ 
subgroup, where HbA1c was moderately out of range 
(OR = 1.07; p < 0.05). Membership of the high risk 
group, where HbA1c levels were extremely deviated 
from targets, was not predicted by depressive 
symptoms. Subgroup membership remained consistent 
over time. 
 
Greater depressive symptoms predicted higher HbA1c 




RR = Retention Rate; DD = Diabetes Duration; n.r. = Not reported  
 
  
Study reference  Sample characteristics Measure of 




Wu, Hilliard, Rausch, 








RR = 89% 
N = 133 (dyads) 
Male = 49% 
 
Mean age = 15.3 ± [1.4 ] 
Age range = 13.1 – 18.5  
 
DD = 5.9 ± [3.8]  
 
Children’s Depression  
Inventory (CDI; 
Kovacs, 1992)  
Children’s Depression  
Inventory – Parent 





18 months  
 
 
Parental reports of adolescent depressive symptoms at 
baseline were correlated with HbA1c at 18 months (r = 
0.229, p = 0.008). No significant association was found 
between adolescent reports of depression at baseline 
and HbA1c at follow up (r = 0.12, p = 0.156). 
 
 
No conclusion can be drawn with regard to 
directionality over time based on self-report however 
parental reports suggest greater depressive symptoms 





Data extraction 2 
Summary of factors explored across the literature reviewed that explored and reported on the influence the relationship between depressive 
symptoms and metabolic control over time (n=9) 
* Studies presented in chronological order. 
CDI = Children’s Depression Inventory; BGM = Blood Glucose Monitoring 
  
Study reference*  Summary of main findings on the influence of variables on the relationship 
between depressive symptoms and HbA1c 
Key variables explored 
Helgeson, Siminerio, 




In a model of predictors of change in HbA1c over a period of 4-years, depressive 
symptoms were not a significant predictor. Bulimic symptoms led to a deterioration 
of HbA1c over time (B = 0.31, p < 0.01) and negative relationships with friends 
also predicted changes in HbA1c over time (B = 0.49, p < 0001).  
 
Body mass index 
Bulimic symptoms 
Peer relationships  
Helgeson, Escobar, 




An increase in depressive symptoms and poorer metabolic control over time were 
predicted by more stressful life events (0.006, p < 0.05; 0.042, p < 0.05). 
 
BGM meter readings were associated with metabolic control (-0.92, p < 0.05). 
Depressive symptoms were not found to be a mediator in the relationship between 
life events and HbA1c when using a meditational analysis for multi-level models.    
 
Stressful life events 
 
Ingerski, Anderson, 
Dolan & Hood (2010) 
 
USA 
Significant predictors of HbA1c at six months included adolescent reports of insulin 
delivery mode (B = -0.21, p < 0.05), duration of illness (B = 0.17, p < 0.05), and 
adolescent (B = 0.19, p < 0.05) and parental (B = 0.31, p < 0.001) reports of family 
conflict. When sociodemographic variables were controlled for adolescent and 
parental reports of baseline depression were not significant predictors of HbA1c at 
6-months. 
 








CDI = Children’s Depression Inventory; BGM = Blood Glucose Monitoring  
Study reference  Summary of main findings on the influence of variables on the relationship 
between depressive symptoms and HbA1c 
Key variables explored 
Guilfoyle, Crimmins 
& Hood (2011) 
 
USA 
At baseline, higher depressive symptoms were correlated with lower self-reported 
BGM (B = -0.05, p < 0.05) and caregiver reported BGM frequency (B = -0.006, p < 
0.01). 
 
Significant correlates of BGM were entered into a model to predict glycemic 
control. HbA1c at 3 months was predicted by BGM frequency reported by 
caregivers (13.42% of variance, B = -0.53, p < 0.001). Caregiver reported BGM 
was the most significant predictor of HbA1c but when depressive symptoms were 
entered into the model, meter downloads was the most significant predictor. 
Depressive symptoms accounted for 5% of the variance in metabolic control. Meter 
downloads of BGM were found to predict HbA1c when depressive symptoms at 
baseline were considered.   
 
Blood glucose monitoring 
Hilliard, Herzer, 
Dolan & Hood  (2011) 
 
USA 
Higher depressive symptoms were correlated with higher HbA1c at baseline (r = 
0.22, p <0.01) but in a model of baseline predictors of HbA1c at 12 months, CDI 
scores were not significant. Depressive symptoms were found to be significant in 
predicting BGM at 12 months (b = -0.05, p < 0.05). 
 
Blood glucose monitoring 
 




The change in HbA1c over time was predicted by change in depressive symptoms 
(B = 0.11, p < 0.001), BGM frequency at baseline (B = -0.21, p = 0.03) and HbA1c 
at baseline (B = -0.23, p = 0.002), with the three-way interactions between these 
variables also significant (p < 0.001).  
 
Blood glucose monitoring 
 
Colton, Olmsted, 




Although disturbed eating behaviour was significantly associated with depressive 
symptoms, HbA1c was not associated with either variable. When BMI at 5 years 
and duration of T1D were controlled for, a multiple regression model revealed that 
CDI scores and eating disorder related psychopathology, and depression and eating 
disorder status at 5-years did not predict HbA1c at 5 years. 
 




CDI = Children’s Depression Inventory; BGM = Blood Glucose Monitoring 
  
Study reference  Summary of main findings on the influence of variables on the relationship 
between depressive symptoms and HbA1c 
Key variables explored 
Hilliard, Wu, Rausch, 
Dolan & Hood (2013) 
 
USA 
Three independent subgroups were established with regard to levels of HbA1c over 
time: Meeting treatment target, Normatively similar, and High risk. The 
membership of subgroups was maintained over the study period.   
 
Higher levels of diabetes-specific family conflict (OR = 1.16, 95%CI; p <0.05) 
reported by caregivers using the Diabetes Family Conflict Scale predicted 
membership of the normatively similar group.  
 
Membership of the high risk group, where HbA1c levels were extremely deviated 
from targets, was predicted by higher negative affect related to BGM (OR = 1.16, 
95% CI; p < 0.05). 
 
Negative emotions related to self-care  
Diabetes specific family conflict 
Wu, Hilliard, Rausch, 
Dolan & Hood (2013) 
 
USA 
HbA1c at 18 months was influenced by levels of parental involvement reported by 
adolescents at baseline, through BGM at 12 months. 
 
Mild levels of adolescent depressive symptoms reported by parents at baseline 
influenced the interaction between adolescent reports of parental involvement in 
diabetes related tasks at baseline and BGM at 12 months (b = 0.33, P = 0.021). 
BGM at 12 months were found to mediate the relationship between baseline 
measures and HbA1c at 18 months (b = -0.26, P = 0.006).  
 
Blood glucose monitoring frequency 






Checklist for Measuring Study Quality (Downs & Black, 1998) 
Reporting 
1. Is the hypothesis/aim/objective of the study clearly described? (Yes=1; No=0) 
2. Are the main outcomes to be measured clearly described in the Introduction or 
Methods section? (Yes=1; No=0) 
3. Are the characteristics of the patients included in the study clearly described? (Yes=1; 
No=0)  
4. Are the interventions of interest clearly described? (Yes=1; No=0) 
5. Are the distributions of principal confounders in each group of subjects to be 
compared clearly described? (Yes=1; No=0) 
6. Are the main findings of the study clearly described? (Yes=1; No=0)  
7. Does the study provide estimates of the random variability in the data for the main 
outcomes? (Yes=1; No=0) 
8. Have all important adverse events that may be a consequence of the intervention been 
reported? (Yes=1; No=0) 
9. Have the characteristics of patients lost to follow-up been described? (Yes=1; No=0) 
10. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the 
main outcomes except where the probability value is less than 0.001? (Yes=1; No=0) 
External validity  
11. Were the subjects asked to participate in the study representative of the entire 
population from which they were recruited? (Yes=1; No=0; Unable to determine=0) 
12. Were those subjects who were prepared to participate representative of the entire 
population from which they were recruited? (Yes=1; No=0; Unable to determine=0) 
13. Were the staff, places, and facilities where the patients were treated, representative of 
the treatment the majority of patients receive? (Yes=1; No=0; Unable to determine=0) 
Internal validity - bias 
14. Was an attempt made to blind study subjects to the intervention they have received? 
(Yes=1; No=0; Unable to determine=0) 
15. Was an attempt made to blind those measuring the main outcomes of the 
intervention? (Yes=1; No=0; Unable to determine=0) 
16. If any of the results of the study were based on “data dredging”, was this made clear? 
(Yes=1; No=0; Unable to determine=0) 
17. In trials and cohort studies, do the analyses adjust for different lengths of follow-up of 
patients, or in case-control studies, is the time period between the intervention and 
outcome the same for cases and controls? (Yes=1; No=0; Unable to determine=0) 
18. Were the statistical tests used to assess the main outcomes appropriate? (Yes=1; 




19. Was compliance with the intervention/s reliable? (Yes=1; No=0; Unable to 
determine=0) 
20. Were the main outcome measures used accurate (valid and reliable)? (Yes=1; No=0; 
Unable to determine=0) 
Internal validity – confounding (selection bias) 
21. Were the patients in different intervention groups (trials and cohort studies) or were 
the cases and controls (case-control studies) recruited from the same population? 
(Yes=1; No=0; Unable to determine=0)  
22. Were study subjects in different intervention groups (trials and cohort studies) or 
were the cases and controls (case-control studies) recruited over the same period of 
time? (Yes=1; No=0; Unable to determine=0) 
23. Were study subjects randomised to intervention groups? (Yes=1; No=0; Unable to 
determine=0) 
24. Was the randomised intervention assignment concealed from both patients and health 
care staff until recruitment was complete and irrevocable? (Yes=1; No=0; Unable to 
determine=0) 
25. Was there adequate adjustment for confounding in the analyses from which the main 
findings were drawn? (Yes=1; No=0; Unable to determine=0) 
26. Were losses of patients to follow-up taken into account? (Yes=1; No=0; Unable to 
determine=0) 
27. Did the study have sufficient power to detect a clinically important effect where the 
probability value for a difference being due chance is less than 5%? (Based on size of 








Part One: About you and your health 
 
Are you: Please tick 
 
□   Male  
□   Female 
 
How old are you? _______ 
 
Which of the following best describes your ethnicity? Please tick. 
 
□   White  
□   Asian or Asian British 
□   Black or Black British 
□   Chinese  
□   Any other Asian background  
□   Mixed background  
□   Other (please state):_______________________________ 
 
  
Do you go to school or college? 
□   Yes  
□   No 
 
If you ticked ‘No’, please tick the box that applies to you.  
□ Working full-time   □  Working part time  □  Not employed 
□   Other (please state):_______________________________ 
 
 
How old were you when you were diagnosed with Type 1 diabetes? _____ 
 
How long have you had Type 1 diabetes? _____ 
 
What do you do to control your diabetes? You can tick more than one box. 
□   I have only changed what I eat (my diet). 
  
□   I take tablets.  
  Please write down how many tablets you take per day: _____ 
 
□   I have insulin injections.  
     Please write down how many injections you have per day: _____  
 
□   I use an insulin pump. 
  










Apart from diabetes, do you have any other health problems? Please tick. 
□   Yes  
□   No 




Have you ever been diagnosed with depression? 
□   Yes  
□   No 
 
If you ticked ‘Yes’, are you currently taking any medication for depression? 
□   Yes  








Adolescent Patient Health Questionnaire (PHQ-9) 
 
Instructions: How often have you been bothered by each of the following symptoms during the past two weeks? For each 














1. Feeling down, depressed, irritable, or hopeless     
2. Little interest or pleasure in doing things     
3. Trouble falling or staying asleep     
4. Poor appetite, weight loss or overeating     
5. Feeling tired or having little energy     
6. Feeling bad about yourself – or feeling that you are a failure or 
have let yourself or your family down 
    
7. Trouble concentrating on things, like school work, reading, or 
watching TV 
    
8. Moving or speaking so slowly that other people could have 
noticed. Or the opposite – being so fidgety or restless that you 
have been moving around a lot more than usual 
    
9. Thoughts that you would be better off dead, or hurting yourself in 
some way 
    
In the past year have you felt depressed or sad most days, even if you felt okay sometimes? 
    Yes                                                                 No                                              
If you are experiencing any problems on this form, how difficult have these problems made it for you to do your work, take 
care of things at home or get along with other people? 
    Not difficult at all                  Somewhat difficult            Very difficult                 Extremely difficult 
Has there been a time in the past month when you have had serious thoughts about ending your life? 
    Yes                                                                 No                                              
Have you EVER in your WHOLE LIFE, tried to kill yourself or made a suicide attempt? 























Adolescent Stress Questionnaire (ASQ) 
 
Here are some statements about things or situations which you might find stressful. Please tell 
us how stressful each of these things or situations has been for you in the past year, by circling 
one number from 1-5 depending on whether you have found this: 
 
1 Not at all stressful (or is irrelevant to me) 
2 A little stressful 
3 Moderately stressful 
4 Quite stressful 
5 Very stressful 
 
Please respond to all items in this section. If you have not experienced something, circle 1 = not at 
all stressful (or is irrelevant to me). 
 
 
1. Disagreements between you and  
    your father      1 2 3 4 5 
 
2. Not being taken seriously    1 2 3 4 5 
 
3. Getting up early in the morning   1 2 3 4 5 
 
4. Little or no control over your life   1 2 3 4 5 
 
5. Having to study things you do  
    not understand     1 2 3 4 5 
 
6. Teachers expecting too much from you  1 2 3 4 5 
 
7. Concern about your future    1 2 3 4 5 
 
8. Being hassled for not fitting in   1 2 3 4 5 
 
9. Keeping up with school work    1 2 3 4 5 
 
10. Employers expecting too much of you  1 2 3 4 5 
       
11. Having to take on new family  
      responsibilities as you get older   1 2 3 4 5 
 
12. Difficulty of some subjects     1 2 3 4 5 
 






1 Not at all stressful (or is irrelevant to me) 
2 A little stressful 
3 Moderately stressful 
4 Quite stressful 
5 Very stressful 
 
 
14. Having to concentrate for too long  
      during school hours     1 2 3 4 5 
 
15. Inadequate school resources   1 2 3 4 5 
 
16. Having to study things you are not   
interested in      1 2 3 4 5 
 
17. Being ignored or rejected by a  
person you want to go out with   1 2 3 4 5 
 
18. Disagreements between you and  
      your teachers     1 2 3 4 5 
 
19. Not enough time to have fun   1 2 3 4 5 
 
20. Putting pressure on yourself to 
meet your goals     1 2 3 4 5 
 
21. Disagreements with your brothers 
and sisters      1 2 3 4 5 
 
22. Pressure to work to make money   1 2 3 4 5 
 
23. Not enough time for leisure activities  1 2 3 4 5 
 
24. Too much homework    1 2 3 4 5 
 
25. Not getting enough feedback on  
schoolwork in time to be helpful   1 2 3 4 5 
 
26. Not enough time for activities  
outside school hours    1 2 3 4 5 
 
27. Making the relationship work with  
your boyfriend/girlfriend    1 2 3 4 5 
 





1 Not at all stressful (or is irrelevant to me) 
2 A little stressful 
3 Moderately stressful 
4 Quite stressful 
5 Very stressful 
 
 
29. Disagreements between your parents  1 2 3 4 5 
 
30. Changes in your physical appearance  
       with growing up     1 2 3 4 5 
 
31. Arguments at home     1 2 3 4 5 
 
32. Pressure to fit in with peers    1 2 3 4 5 
 
33. Compulsory school attendance   1 2 3 4 5 
 
34. Having to make decisions about 
future work or education    1 2 3 4 5 
 
35. Living at home     1 2 3 4 5 
 
36. Satisfaction with how you look   1 2 3 4 5 
 
37. Disagreements between you and 
your mother    1 2 3 4 5 
 
38. Not enough money to buy the things  
you want      1 2 3 4 5 
 
39. Going to school     1 2 3 4 5 
 
40. Not enough time for your boyfriend/ 
girlfriend      1 2 3 4 5 
 
41. Teachers hassling you about the 
way you look     1 2 3 4 5 
 
42. Abiding by petty rules at school   1 2 3 4 5 
 
43. Pressure of study     1 2 3 4 5 
 














1 Not at all stressful (or is irrelevant to me) 
2 A little stressful 
3 Moderately stressful 
4 Quite stressful 
5 Very stressful 
 
45. Not being listened to by teachers   1 2 3 4 5 
 
46. Parents expecting too much from you  1 2 3 4 5 
 
47. Having to take on new financial  
      responsibilities as you grow older   1 2 3 4 5 
 
48. Lack of understanding by parents   1 2 3 4 5 
 
49. Parents hassling you about the  
way you look     1 2 3 4 5 
 
50. Work interfering with school and  
      social activities     1 2 3 4 5 
 
51. Not enough money to buy the things 
you need      1 2 3 4 5 
 
52. Getting along with your boyfriend/ 
girlfriend      1 2 3 4 5 
 
53. Lack of freedom     1 2 3 4 5 
 
54. Peers hassling you about the  
way you look     1 2 3 4 5 
 
55. Lack of respect from teachers    1 2 3 4 5 
 
56. Disagreements between you and 
your peers      1 2 3 4 5 
 
57. Getting along with your teachers   1 2 3 4 5 
 
58. Breaking up with your boyfriend/ 














Problem Areas In Diabetes Questionnaire (PAID-T) 
 
INSTRUCTIONS: Which of the following diabetes issues are currently a problem for you? 














 0 1 2 3 4 
1. Not having clear and concrete goals for 
your diabetes care 
0 1 2 3 4 
2. Feeling discouraged with your diabetes 
treatment plan? 
0 1 2 3 4 
3. Feeling scared when you think about living 
with diabetes? 
0 1 2 3 4 
4. Uncomfortable social situations related to 
your diabetes care (e.g., people telling you 
what to eat)? 
0 1 2 3 4 
5. Feelings of deprivation regarding food and 
meals? 
0 1 2 3 4 
6. Feeling depressed when you think about 
living with diabetes? 
0 1 2 3 4 
7. Not knowing if your mood or feelings are 
related to your diabetes 
0 1 2 3 4 
8. Feeling overwhelmed by your diabetes?  0 1 2 3 4 
9. Worrying about low blood sugar reactions? 0 1 2 3 4 
10. Feeling angry when you think about living 
with diabetes? 
0 1 2 3 4 
11. Feeling constantly concerned about food 
and eating? 
0 1 2 3 4 
12. Worrying about the future and the 
possibility of serious complications? 
0 1 2 3 4 
13. Feelings of guilt or anxiety when you get 
off track with your diabetes management? 
0 1 2 3 4 
14. Not "accepting" your diabetes? 0 1 2 3 4 
15. Feeling unsatisfied with your diabetes 
physician? 
0 1 2 3 4 
16. Feeling that diabetes is taking up too 
much of your mental and physical energy 
every day? 
0 1 2 3 4 
17. Feeling alone with your diabetes? 0 1 2 3 4 
18. Feeling that your friends and family are 
not supportive of your diabetes management 
efforts? 
0 1 2 3 4 
19. Coping with complications of diabetes? 0 1 2 3 4 
20. Feeling "burned out" by the constant 
effort needed to manage diabetes? 






Automatic Thoughts Questionnaire (ATQ) 
 
Listed below are a variety of thoughts that pop into people's heads. Please read each thought and 
indicate how frequently, if at all, the thought occurred to you over the last week. Please read each item 
carefully and fill in the blank with the appropriate number; using the following scale: 
 
1 = Not at all 
2 = Sometimes 
3 = Moderately often 
4 = Often 
5 = All the time 
 
_____ 1. I feel like I'm up against the world. 
_____ 2. I'm no good. 
_____ 3. Why can't I ever succeed? 
_____ 4. No one understands me. 
_____ 5. I've let people down. 
_____ 6. I don't think I can go on. 
_____ 7. I wish I were a better person. 
_____ 8. I'm so weak. 
_____ 9. My life's not going the way I want it to. 
_____ 10. I'm so disappointed in myself. 
_____ 11. Nothing feels good anymore. 
_____ 12. I can't stand this anymore. 
_____ 13. I can't get started. 
_____ 14. What's wrong with me? 
_____ 15. I wish I were somewhere else. 
_____ 16. I can't get things together. 
_____ 17. I hate myself. 
_____ 18. I'm worthless. 
_____ 19. I wish I could just disappear. 
_____ 20. What's the matter with me? 
_____ 21. I'm a loser. 
_____ 22. My life is a mess. 
_____ 23. I'm a failure. 
_____ 24. I'll never make it. 
_____ 25. I feel so helpless. 
_____ 26. Something has to change. 
_____ 27. There must be something wrong with me. 
_____ 28. My future is bleak. 
_____ 29. It's just not worth it. 










Self-Efficacy Questionnaire for Children (SEQ-C) 
Circle the answer that best shows how well you do in each of the following situations. 
 
 Not at all    Very well 
 1 2 3 4 5 
1. How well can you get teachers to help you when 
you get stuck on schoolwork? 
1 2 3 4 5 
2. How well can you express your opinions when other 
classmates disagree with you? 
1 2 3 4 5 
3. How well do you succeed in cheering yourself up 
when an unpleasant event has happened? 
1 2 3 4 5 
4. How well can you study when there are other 
interesting things to do? 
1 2 3 4 5 
5. How well do you succeed in becoming calm again 
when you are very scared? 
1 2 3 4 5 
6. How well can you become friends with other 
children? 
1 2 3 4 5 
7. How well can you study a chapter for a test?  1 2 3 4 5 
8. How well can you have a chat with an unfamiliar 
person? 
1 2 3 4 5 
9. How well can you prevent to become nervous? 1 2 3 4 5 
10. How well do you succeed in finishing all your 
homework every day? 
1 2 3 4 5 
11. How well can you work in harmony with your 
classmates? 
1 2 3 4 5 
12. How well can you control your feelings?  1 2 3 4 5 
13. How well can you pay attention during every 
class? 
1 2 3 4 5 
14. How well can you tell other children that they are 
doing something that you don’t like? 
1 2 3 4 5 
15. How well can you give yourself a pep-talk when 
you feel low? 
1 2 3 4 5 
16. How well do you succeed in understanding all 
subjects in school? 
1 2 3 4 5 
17. How well can you tell a funny event to a group of 
children? 
1 2 3 4 5 
18. How well can you tell a friend that you don’t feel 
well? 
1 2 3 4 5 
19. How well do you succeed in satisfying your 
parents with your schoolwork? 
1 2 3 4 5 
20. How well do you succeed in staying friends with 
other children? 
1 2 3 4 5 
21. How well do you succeed in suppressing 
unpleasant thoughts? 




22. How well do you succeed in passing a test?  1 2 3 4 5 
23. How well do you succeed in preventing quarrels 
with other children? 
1 2 3 4 5 
24. How well do you succeed in not worrying about 
things that might happen? 







Self-Efficacy for Diabetes Self-Management Questionnaire (SEDM) 
 
Please answer the following questions about taking care of your diabetes. 
 
 
How sure are you that you can do 
each of the following, almost all of 
the time? 
 
Not at All                                                                  Completely 
Sure                                                                                   Sure 
 
1.  Adjust your insulin correctly when 
you eat more or less than usual? 
 
 
1        2        3        4        5        6        7        8        9        10 
 
2. Choose healthful foods when you 
go out to eat? 
 
1        2        3        4        5        6        7        8        9        10 
 
3. Exercise even when you don’t 
really feel like it? 
 
1        2        3        4        5        6        7        8        9        10 
 
4. Adjust your insulin or food 
accurately based on how much 
exercise you get? 
1        2        3        4        5        6        7        8        9        10 
 
5. Talk to your doctor or nurse about 
any problems you’re having with 
taking care of your diabetes? 
1        2        3        4        5        6        7        8        9        10 
 
6. Do your blood sugar checks even 
when you are really busy? 
 
1        2        3        4        5        6        7        8        9        10 
 
7. Manage your diabetes the way 
your health care team wants you to? 
 
1        2        3        4        5        6        7        8        9        10 
 
8. Manage your diabetes even when 
you feel overwhelmed? 
 
1        2        3        4        5        6        7        8        9        10 
 
9. Find ways to deal with feeling 
frustrated about your diabetes? 
 
1        2        3        4        5        6        7        8        9        10 
 
10. Identify things that could get in 
the way of managing your diabetes? 
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School of Psychology 
 
Edgbaston 
Birmingham B15 2TT 
United Kingdom 
Telephone 0121 414 7214 
Fax 0121 414  4897 
 
 
Dear Young Person and Parent/Guardian, 
 
Re: Wellbeing in adolescents with type 1 diabetes 
 
I am a Trainee Clinical Psychologist at the University of Birmingham. As part of my training I am doing a 
research project about wellbeing in young people with Type 1 diabetes. The research aims to find out more about 
the thoughts of young people with Type 1 diabetes and their parents. By improving understanding of wellbeing 
in young people with Type 1 diabetes health professionals’ will be in a better position to provide the young 
person with the support they require.  
 
The research involves completing questionnaires about thoughts and experiences of Type 1 diabetes. As you are 
currently attending this clinic for young people with Type 1 diabetes, your responses are very important. The 
attached information sheet will provide you with more information on the research. If you have any questions, I 
will be available after your appointment today and also your next appointment to go through the information 
with you. You can then take some more time to decide whether you would like to participate. Alternatively, you 
can contact me using the details below. You may find it helpful to talk to someone you feel comfortable talking 
with about the research before you make a decision.  
 
If you decide that you would like to take part, I would be grateful of you could complete the reply slip at the 
bottom of this letter and return it to the diabetes team at your appointment. You have the option of completing 
the questionnaires now or at the type 1 diabetes clinic at your next appointment. The questionnaire should take 
no longer than 30 minutes to complete.  
 
Many thanks for taking the time to read this letter.  
 




Trainee Clinical Psychologist 
 
Contact details:  Clinical Psychology Doctorate Course 
   School of Psychology 
   University of Birmingham 
   Birmingham 
   B15 2TT 
   Tel: 0121 414 7124 







Title of Research: Wellbeing in adolescents with type 1 diabetes 
 
Name of Researcher: Kiran Bali 
 
Please state your preferred choice from the options below: 
 
 
I would like to meet with the researcher to complete the questionnaires now. 
 
 
I would like to meet with the researcher to complete the questionnaires at my next 
appointment at this clinic on __________(please insert date, if known)  at ________ (time). 
 
























































Consent Form (Young Person 13 – 18 years)  
 
Title of Research: Wellbeing in adolescents with type 1 diabetes  
 
Name of Researcher: Kiran Bali 
 
If you have decided that you would like to take part in this research, please read each statement and 
place an initial in the corresponding box to show that you have understood what the research is about. 
 
I confirm that I have read and understood the information sheet dated 13/02/13 (version 2) for 
the above study.  I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
I understand that participation is voluntary and that I am free to withdraw at any time during 
the research, without giving any reason, without my medical care or legal rights being 
affected. 
 
I understand that sections of my medical notes that are relevant to taking part in the research 
(e.g. metabolic control) may be looked at by the researcher and agree that this can be done.  
 
I agree to take part in the above study. 
 
 

























SPSS Output: General model mediation analysis 
 
Run MATRIX procedure: 
 
***************** PROCESS Procedure for SPSS Release 2.11 **************** 
 
          Written by Andrew F. Hayes, Ph.D.       www.afhayes.com 
    Documentation available in Hayes (2013). www.guilford.com/p/hayes3 
 
************************************************************************** 
Model = 4 
    Y = ZPHQTota 
    X = Zasqlog 
   M1 = ZSEQCTot 
   M2 = ZSEDMTot 
   M3 = ZATQTota 
 
Sample size 






          R       R-sq          F        df1        df2          p 
      .2932      .0860     4.8913     1.0000    52.0000      .0314 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1313      .0000     1.0000     -.2636      .2636 






          R       R-sq          F        df1        df2          p 
      .1200      .0144      .7592     1.0000    52.0000      .3876 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1364      .0000     1.0000     -.2737      .2737 






          R       R-sq          F        df1        df2          p 
      .9797      .9599  1244.9604     1.0000    52.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .0275      .0000     1.0000     -.0552      .0552 






          R       R-sq          F        df1        df2          p 






              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1120      .0000     1.0000     -.2251      .2251 
ZSEQCTot     -.0694      .1248     -.5562      .5806     -.3202      .1814 
ZSEDMTot     -.1383      .1204    -1.1490      .2561     -.3803      .1036 
ZATQTota    -1.2011      .5719    -2.1002      .0409    -2.3503     -.0518 
Zasqlog      1.6792      .5750     2.9202      .0053      .5237     2.8348 
 




          R       R-sq          F        df1        df2          p 
      .5395      .2910    21.3447     1.0000    52.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1157      .0000     1.0000     -.2321      .2321 
Zasqlog       .5395      .1168     4.6200      .0000      .3052      .7738 
 
***************** TOTAL, DIRECT, AND INDIRECT EFFECTS ******************** 
 
Total effect of X on Y 
     Effect         SE          t          p       LLCI       ULCI 
      .5395      .1168     4.6200      .0000      .3052      .7738 
 
Direct effect of X on Y 
     Effect         SE          t          p       LLCI       ULCI 
     1.6792      .5750     2.9202      .0053      .5237     2.8348 
 
Indirect effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL       -1.1398      .7494    -2.7801      .3121 
ZSEQCTot      .0204      .0774     -.0841      .2160 
ZSEDMTot      .0166      .0312     -.0191      .1096 
ZATQTota    -1.1767      .7540    -2.8800      .2333 
(C1)          .0038      .0950     -.1426      .2259 
(C2)         1.1971      .7641     -.2186     2.8692 
(C3)         1.1933      .7562     -.2522     2.8522 
 
Partially standardized indirect effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL       -1.1398      .7306    -2.5151      .4396 
ZSEQCTot      .0204      .0733     -.0948      .1978 
ZSEDMTot      .0166      .0329     -.0197      .1353 
ZATQTota    -1.1767      .7287    -2.5530      .3474 
 
Completely standardized indirect effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL       -1.1398      .7178    -2.4621      .4379 
ZSEQCTot      .0204      .0726     -.0957      .1911 
ZSEDMTot      .0166      .0314     -.0202      .1266 
ZATQTota    -1.1767      .7164    -2.5048      .3688 
 
Ratio of indirect to total effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL       -2.1128     1.5882    -5.7156      .6091 
ZSEQCTot      .0377      .1417     -.1794      .3869 
ZSEDMTot      .0308      .0599     -.0339      .2638 
ZATQTota    -2.1813     1.6018    -5.8731      .5035 
 
Ratio of indirect to direct effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 




ZSEQCTot      .0121      .7015     -.0607      .2802 
ZSEDMTot      .0099      .3518     -.0162      .0929 
ZATQTota     -.7008     6.6297     -.8806      .8216 
 
Specific indirect effect contrast definitions 
(C1)   ZSEQCTot   minus      ZSEDMTot 
(C2)   ZSEQCTot   minus      ZATQTota 
(C3)   ZSEDMTot   minus      ZATQTota 
 
******************** ANALYSIS NOTES AND WARNINGS ************************* 
 
Number of bootstrap samples for bias corrected bootstrap confidence intervals: 
     5000 
 
Level of confidence for all confidence intervals in output: 
    95.00 
 








SPSS Output: Diabetes specific model mediation analysis 
 
 
Run MATRIX procedure: 
 
***************** PROCESS Procedure for SPSS Release 2.11 **************** 
 
          Written by Andrew F. Hayes, Ph.D.       www.afhayes.com 
    Documentation available in Hayes (2013). www.guilford.com/p/hayes3 
 
************************************************************************** 
Model = 4 
    Y = ZPHQTota 
    X = ZPAIDTTo 
   M1 = ZSEQCTot 
   M2 = ZSEDMTot 
   M3 = ZATQTota 
 
Sample size 






          R       R-sq          F        df1        df2          p 
      .2621      .0687     3.8370     1.0000    52.0000      .0555 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1326      .0000     1.0000     -.2660      .2660 






          R       R-sq          F        df1        df2          p 
      .3298      .1088     6.3462     1.0000    52.0000      .0149 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1297      .0000     1.0000     -.2603      .2603 






          R       R-sq          F        df1        df2          p 
      .5586      .3120    23.5795     1.0000    52.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .1140      .0000     1.0000     -.2287      .2287 










      .7303      .5333    13.9994     4.0000    49.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .0967      .0000     1.0000     -.1943      .1943 
ZSEQCTot     -.1025      .1062     -.9646      .3395     -.3160      .1110 
ZSEDMTot      .0667      .1075      .6208      .5376     -.1492      .2826 
ZATQTota      .0960      .1198      .8013      .4268     -.1447      .3366 
ZPAIDTTo      .6580      .1238     5.3142      .0000      .4092      .9069 
 




          R       R-sq          F        df1        df2          p 
      .7165      .5134    54.8539     1.0000    52.0000      .0000 
 
Model 
              coeff         se          t          p       LLCI       ULCI 
constant      .0000      .0958      .0000     1.0000     -.1923      .1923 
ZPAIDTTo      .7165      .0967     7.4063      .0000      .5224      .9106 
 
***************** TOTAL, DIRECT, AND INDIRECT EFFECTS ******************** 
 
Total effect of X on Y 
     Effect         SE          t          p       LLCI       ULCI 
      .7165      .0967     7.4063      .0000      .5224      .9106 
 
Direct effect of X on Y 
     Effect         SE          t          p       LLCI       ULCI 
      .6580      .1238     5.3142      .0000      .4092      .9069 
 
Indirect effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL         .0585      .0877     -.0947      .2166 
ZSEQCTot      .0269      .0702     -.0297      .2768 
ZSEDMTot     -.0220      .0425     -.1346      .0452 
ZATQTota      .0536      .0782     -.1004      .2078 
(C1)          .0489      .1025     -.0669      .3688 
(C2)         -.0267      .1187     -.2097      .3091 
(C3)         -.0756      .0792     -.2396      .0720 
 
Partially standardized indirect effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL         .0585      .0940     -.0961      .2292 
ZSEQCTot      .0269      .0651     -.0368      .2483 
ZSEDMTot     -.0220      .0435     -.1275      .0544 
ZATQTota      .0536      .0853     -.0935      .2291 
 
Completely standardized indirect effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL         .0585      .0900     -.0979      .2196 
ZSEQCTot      .0269      .0629     -.0347      .2353 
ZSEDMTot     -.0220      .0417     -.1228      .0508 
ZATQTota      .0536      .0825     -.0951      .2248 
 
Ratio of indirect to total effect of X on Y 
             Effect    Boot SE   BootLLCI   BootULCI 
TOTAL         .0816      .1301     -.1302      .3177 
ZSEQCTot      .0375      .0905     -.0477      .3479 
ZSEDMTot     -.0307      .0601     -.1786      .0708 
ZATQTota      .0748      .1175     -.1283      .3179 
 
Ratio of indirect to direct effect of X on Y 




TOTAL         .0888      .2866     -.1152      .4656 
ZSEQCTot      .0408      .1266     -.0583      .4744 
ZSEDMTot     -.0334      .0805     -.2098      .1015 
ZATQTota      .0815      .2431     -.1264      .4817 
 
Specific indirect effect contrast definitions 
(C1)   ZSEQCTot   minus      ZSEDMTot 
(C2)   ZSEQCTot   minus      ZATQTota 
(C3)   ZSEDMTot   minus      ZATQTota 
 
******************** ANALYSIS NOTES AND WARNINGS ************************* 
 
Number of bootstrap samples for bias corrected bootstrap confidence intervals: 
     5000 
 
Level of confidence for all confidence intervals in output: 
    95.00 
 
------ END MATRIX ----- 
 
 
 
 
